data_2lj2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lj2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.3 -29.73 67.66 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.033 0.444 . . . . 0.0 110.508 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.85 -47.92 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.466 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.61 65.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.53 -30.48 71.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.037 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 24' ' ' THR . 9.2 t -50.71 -19.83 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.034 0.533 . . . . 0.0 111.004 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.1 p -58.93 -21.23 57.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -87.48 -8.34 56.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.648 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.492 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.6 m -60.62 -48.62 92.82 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.736 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 24' ' ' THR . 32.2 Cg_endo -60.71 -40.28 56.28 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 121.512 1.475 . . . . 0.0 111.55 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -75.12 -25.78 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.688 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.1 tp -73.18 -37.52 66.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.887 -0.508 . . . . 0.0 110.584 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.9 -50.08 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.403 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.15 -32.01 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.149 0.499 . . . . 0.0 110.432 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -45.06 77.39 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.207 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.55 -38.21 90.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.32 1.057 . . . . 0.0 111.133 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.1 -43.43 88.56 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.771 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.2 t -61.38 -44.32 98.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.89 -34.52 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.07 -51.09 60.42 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.17 -32.53 71.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -59.21 -18.56 37.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.859 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.36 -37.54 72.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 109.759 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -49.18 -24.58 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.592 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -95.58 10.99 34.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.125 0.488 . . . . 0.0 110.294 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.23 151.33 21.95 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.41 145.78 43.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.735 -0.274 . . . . 0.0 111.103 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.6 tp -44.36 -42.33 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.945 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 64.5 t0 -88.39 -30.27 19.62 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -88.96 0.4 56.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.677 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 9.2 p -101.91 -1.09 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.792 1.178 . . . . 0.0 109.931 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.81 -35.17 20.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.23 0.538 . . . . 0.0 111.892 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -52.58 1.19 Allowed Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.21 -34.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.994 2.462 . . . . 0.0 115.176 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -70.72 -48.82 52.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.312 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 tp -71.28 -27.38 63.38 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.18 63.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 4.0 pt -63.02 -40.95 90.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.978 0.418 . . . . 0.0 110.803 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 76.0 t80 -59.77 -36.27 76.33 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.727 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 55' ' ' ILE . 40.0 mm -64.17 -42.56 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.47 -41.5 97.14 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.2 mt -72.66 -32.57 65.93 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.798 -0.236 . . . . 0.0 110.707 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 m -55.28 -57.68 10.82 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.599 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.38 -30.11 48.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 45.0 t80 -62.86 -28.01 69.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.13 91.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.481 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.77 -22.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -66.6 -47.47 72.59 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -54.23 -40.35 67.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 0.0 111.557 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -70.34 -40.31 74.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.821 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -69.4 -44.85 70.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.159 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ALA . 11.7 tp-100 -49.82 -46.15 50.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.641 ' HG1' ' N ' ' A' ' 17' ' ' LEU . 25.9 p . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.641 ' N ' ' HG1' ' A' ' 16' ' ' THR . 10.9 mp -71.45 -29.9 65.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.028 0.442 . . . . 0.0 110.91 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -60.33 -48.75 86.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.0 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.82 -24.62 65.31 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.336 0.588 . . . . 0.0 110.602 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.1 tp -62.31 -30.35 71.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.911 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.598 ' O ' ' OG1' ' A' ' 24' ' ' THR . 32.5 t -50.89 -19.52 1.03 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -57.53 -20.54 32.39 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.384 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 26' ' ' VAL . 55.7 m-85 -86.14 -10.83 54.08 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.734 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 21' ' ' SER . 2.2 p -55.88 -49.08 95.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.394 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -58.37 -43.27 47.74 Favored 'Trans proline' 0 N--CA 1.511 2.501 0 C-N-CA 122.408 2.072 . . . . 0.0 113.012 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -76.34 -25.34 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.089 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.42 -38.18 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.517 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.82 -51.64 70.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.982 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 29' ' ' ILE . 94.3 mt -63.97 -42.58 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -53.13 -45.09 68.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.36 -37.25 86.47 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.19 0.995 . . . . 0.0 111.452 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.73 -42.99 69.21 Favored Glycine 0 CA--C 1.543 1.811 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.134 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -57.75 -33.72 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.13 -39.32 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.04 -51.51 53.37 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 119.192 -1.48 . . . . 0.0 109.542 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.46 -32.13 69.96 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.995 0.426 . . . . 0.0 110.038 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t -57.32 -17.85 14.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.51 -38.84 75.31 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -48.25 -25.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.917 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 m -96.2 9.82 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 110.436 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.87 150.74 21.76 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.09 146.68 43.42 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.262 -0.175 . . . . 0.0 110.77 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.8 tp -43.86 -43.5 6.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.771 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 37.7 p30 -89.02 -29.85 19.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.1 t80 -88.35 0.29 56.34 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.671 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 6.7 p -100.02 0.44 10.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-N 119.56 1.073 . . . . 0.0 109.839 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -85.67 -34.93 21.19 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.151 -0.968 . . . . 0.0 112.379 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 -52.19 1.22 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' CD ' ' H ' ' A' ' 50' ' ' ALA . 82.8 Cg_endo -91.62 -34.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.492 2.128 . . . . 0.0 114.967 -177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -70.51 -50.4 38.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.239 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 tp -70.59 -27.26 63.97 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.935 0.397 . . . . 0.0 111.043 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.46 65.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.896 0.379 . . . . 0.0 111.672 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.91 -33.17 71.51 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.47 -42.33 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.61 98.26 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.486 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -32.09 68.52 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.863 -0.198 . . . . 0.0 110.664 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -56.33 -58.35 8.38 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.172 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.02 -27.71 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.078 0.466 . . . . 0.0 110.778 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -66.16 -29.39 69.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.53 83.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.381 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 pt -70.64 -21.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.84 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -66.28 -49.19 67.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -49.31 -31.54 9.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.709 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -76.33 -54.29 6.97 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.93 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.25 -44.09 95.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.119 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.33 -38.45 63.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.544 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.25 -28.8 64.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.294 0.568 . . . . 0.0 110.732 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -60.1 -46.14 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.847 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.74 65.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.478 0.656 . . . . 0.0 110.898 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.54 -29.62 68.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.039 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 34.0 t -52.21 -21.33 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.685 0.279 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.2 m -59.27 -20.5 54.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LEU . 72.6 m-85 -89.87 -10.04 46.77 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.567 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.622 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 m -56.66 -48.06 97.88 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 24' ' ' THR . 34.2 Cg_endo -61.96 -37.05 68.24 Favored 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 122.372 2.048 . . . . 0.0 111.938 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.01 -26.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.939 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 23' ' ' PHE . 52.2 tp -77.24 -40.63 44.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.659 0.266 . . . . 0.0 111.517 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 29' ' ' ILE . 7.7 p -60.42 -52.33 62.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.792 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 ' H ' ' CG1' ' A' ' 28' ' ' VAL . 10.4 tp -64.09 -39.07 84.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 109.659 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.2 tp -52.8 -44.27 66.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.555 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.93 -34.26 77.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.963 0.887 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.48 -42.09 74.61 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.289 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.49 -32.02 35.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' ' OG ' ' A' ' 37' ' ' SER . 41.0 t -63.06 -33.23 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -51.24 60.03 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.55 -29.06 58.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 4.0 p -55.56 -17.16 4.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.934 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.29 -38.79 77.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mp -49.68 -23.8 1.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.786 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 37' ' ' SER . 30.4 p -94.57 11.17 31.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.299 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.95 154.66 24.76 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 46' ' ' VAL . 1.1 t80 -73.5 147.79 43.73 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.632 -0.334 . . . . 0.0 110.268 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -44.57 -44.25 8.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.44 -0.315 . . . . 0.0 110.416 -176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 47.0 p-10 -88.94 -30.36 18.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 8.3 t80 -88.69 1.24 55.46 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.312 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 8.3 p -100.26 1.02 10.48 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-N 119.493 1.042 . . . . 0.0 110.701 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.87 -31.88 23.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.635 0.731 . . . . 0.0 112.797 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.29 -51.58 13.26 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.432 -178.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 72.7 Cg_endo -83.84 -26.5 1.97 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 123.565 2.844 . . . . 0.0 113.465 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -68.95 -50.52 48.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.562 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.29 -27.66 64.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.052 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.2 -29.31 67.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 111.574 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 53' ' ' ILE . 34.2 mm -65.93 -43.65 92.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.174 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' O ' ' OG1' ' A' ' 58' ' ' THR . 78.0 m-85 -62.24 -32.65 73.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.39 -41.86 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.81 -41.97 97.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.862 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 3.9 mm? -73.06 -31.37 64.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 25.3 m -56.68 -59.36 5.12 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.583 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.21 -27.47 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.76 -27.1 69.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.742 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.76 97.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.222 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.6 mt -68.35 -21.99 26.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -66.99 -48.01 69.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -49.41 -34.46 16.43 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.898 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -77.18 -55.7 5.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.885 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -59.94 -44.0 94.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.839 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -55.47 -38.52 69.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.733 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.818 -179.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.09 -29.05 64.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.184 0.516 . . . . 0.0 110.941 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -60.25 -47.48 92.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.735 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.82 66.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.573 0.701 . . . . 0.0 110.768 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.69 -28.62 68.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.4 p -51.69 -20.95 2.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.175 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 m -58.35 -19.97 39.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 27' ' ' LEU . 69.9 m-85 -89.59 -10.48 45.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.65 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.633 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 6.6 m -55.5 -48.87 95.41 Favored Pre-proline 0 CA--C 1.528 0.125 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -60.98 -36.48 82.61 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.786 2.324 . . . . 0.0 111.558 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -79.13 -25.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.899 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' PHE . 55.5 tp -74.19 -39.56 63.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.019 0.438 . . . . 0.0 112.122 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 29' ' ' ILE . 3.9 m -60.61 -52.05 65.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' H ' HG23 ' A' ' 28' ' ' VAL . 22.4 pt -63.79 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.93 -43.93 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.357 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.3 -34.68 78.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.94 0.876 . . . . 0.0 111.067 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.68 94.49 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.91 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.4 -47.42 86.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.3 -31.83 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.821 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.53 -52.3 52.66 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.196 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 97.9 mt -55.51 -29.13 58.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -54.59 -15.7 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.017 0.823 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.84 -40.37 84.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 111.716 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -44.02 -23.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.535 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m -93.73 11.72 28.11 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.679 0.752 . . . . 0.0 109.48 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.71 152.93 22.8 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.37 146.59 42.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.544 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' CD1' ' H ' ' A' ' 43' ' ' LEU . 11.0 mp -43.82 -44.92 7.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.373 -0.204 . . . . 0.0 111.498 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 66.4 t0 -88.74 -31.3 18.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.92 2.69 50.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.188 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 9.9 p -101.95 0.78 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.151 0.887 . . . . 0.0 110.384 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.05 -34.68 17.89 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.049 -1.032 . . . . 0.0 112.912 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -79.42 -53.02 1.09 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.007 -177.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' H ' ' A' ' 50' ' ' ALA . 73.8 Cg_endo -90.29 -35.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 122.424 2.083 . . . . 0.0 113.919 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -72.02 -51.93 19.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.249 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.5 -28.02 67.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.892 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.54 -28.05 65.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.402 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.96 -43.76 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.532 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -61.56 -32.21 72.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.627 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -63.62 -41.39 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.53 96.72 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.64 -31.4 65.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -56.68 -60.38 3.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.555 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.85 -27.96 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-O 120.863 0.363 . . . . 0.0 110.527 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.433 ' HH ' HG23 ' A' ' 24' ' ' THR . 36.7 t80 -62.04 -27.14 68.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.164 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.38 97.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.357 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.96 -21.96 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.69 -46.38 75.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -49.52 -30.16 7.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.193 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.11 -56.74 4.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -58.97 -44.63 91.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.247 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.37 -30.18 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.38 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.813 -179.741 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.09 -30.39 68.69 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.217 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.17 -47.38 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.341 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.08 66.79 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -30.26 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.015 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 24' ' ' THR . 8.2 m -50.31 -20.18 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.859 0.464 . . . . 0.0 110.7 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 6.4 m -57.87 -19.7 31.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -88.09 -10.74 49.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.82 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -58.78 -43.67 98.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.29 -177.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 37.8 Cg_exo -63.15 -43.22 19.65 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.011 2.474 . . . . 0.0 111.212 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.28 -25.65 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.35 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.6 tt -72.58 -38.02 68.0 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.933 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.49 -51.25 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.107 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.57 -35.06 73.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.44 -44.1 80.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.555 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.9 -36.9 85.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.55 1.166 . . . . 0.0 110.797 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.78 76.84 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.908 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.22 -34.86 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.86 -35.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.302 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.49 -51.79 56.7 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.28 -33.34 74.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.5 m -58.91 -18.8 36.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.741 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.57 79.67 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 109.968 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -25.53 25.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.1 6.98 47.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.147 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.07 155.21 24.29 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.02 145.81 44.24 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.736 -0.273 . . . . 0.0 111.247 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 tp -43.03 -41.64 3.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.644 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -87.57 -27.43 22.57 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -86.04 1.32 50.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.067 -1.424 . . . . 0.0 113.184 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -96.76 1.06 10.52 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.026 0 CA-C-N 119.738 1.154 . . . . 0.0 110.614 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 mt -83.38 -32.56 26.12 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 111.437 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.59 -52.12 63.25 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.158 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.74 -36.89 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.27 1.313 . . . . 0.0 110.992 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.41 -53.93 8.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.835 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.54 -37.07 82.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.871 -0.518 . . . . 0.0 110.943 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.96 71.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.441 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.89 -44.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.924 0.392 . . . . 0.0 110.97 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 59.0 t80 -64.47 -36.78 85.29 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.152 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.97 -42.87 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.99 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.54 -42.58 99.69 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.618 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.868 0.334 . . . . 0.0 110.635 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 53.5 m -55.8 -58.83 6.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.449 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.71 -29.17 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.61 -29.17 70.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.16 80.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.193 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 62' ' ' ILE . 37.8 mm -68.6 -22.59 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.877 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -66.88 -49.52 65.36 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.685 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -54.34 -41.23 68.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.442 0.639 . . . . 0.0 111.333 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.15 -40.36 71.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.624 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -71.07 -45.63 63.41 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.382 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -50.26 -49.94 51.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.405 179.21 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.25 52.2 tp -47.29 -35.0 7.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.86 -32.77 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.874 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -74.04 -20.27 60.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.788 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.86 -46.85 88.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.158 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -75.59 -25.86 57.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 110.097 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -61.37 -21.87 64.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.407 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 70.8 m-85 -87.38 -8.12 56.96 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.304 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.506 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m -61.85 -49.38 86.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.479 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 24' ' ' THR . 27.6 Cg_endo -59.93 -41.6 52.11 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.429 1.419 . . . . 0.0 111.26 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.87 -25.99 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.598 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.1 tt -71.76 -37.34 70.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.292 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.53 -50.18 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.13 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.42 -36.91 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.113 0.483 . . . . 0.0 109.702 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.12 -46.35 65.31 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.67 -37.8 88.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.146 0.974 . . . . 0.0 111.484 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.14 -43.83 93.3 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.921 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.36 -44.39 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.23 -38.19 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.6 -51.7 54.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.65 -34.0 74.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.193 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -58.19 -18.2 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.18 81.66 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.91 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 tp -50.71 -25.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.34 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -95.86 9.87 39.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.54 22.62 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 147.3 44.39 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.686 -0.302 . . . . 0.0 110.614 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 mt -44.86 -44.91 9.93 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.338 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.74 -30.3 19.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -88.0 -0.68 57.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.298 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.3 2.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 119.301 0.955 . . . . 0.0 110.204 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.87 -32.69 27.28 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 110.607 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.2 mp -51.72 -52.89 56.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.922 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.5 Cg_endo -73.88 -36.02 3.9 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.052 1.168 . . . . 0.0 111.583 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.13 -53.53 10.23 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.158 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 10.8 mp -66.16 -35.38 80.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.19 0.45 . . . . 0.0 110.297 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.4 70.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.454 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.97 -43.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.48 -34.43 77.74 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.36 -42.31 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.5 97.99 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.442 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -73.43 -32.03 64.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.5 m -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.743 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.5 -29.48 46.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.19 -27.42 68.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.23 0.538 . . . . 0.0 112.235 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.63 -44.12 97.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.497 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 62' ' ' ILE . 96.5 mt -69.6 -22.35 25.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.454 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -67.04 -47.56 71.0 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.369 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -50.76 -37.66 43.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.326 0.584 . . . . 0.0 110.958 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -71.46 -43.98 65.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.768 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -70.36 -46.62 63.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.215 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.7 -29.98 70.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.741 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.785 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -54.39 -43.67 71.61 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.616 0.644 . . . . 0.0 111.823 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.79 -32.5 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.14 -42.71 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.776 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -74.27 -26.24 60.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.342 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 52.5 p -61.38 -22.73 65.23 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 27' ' ' LEU . 84.2 m-85 -87.42 -9.38 54.84 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.671 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.54 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 3.1 m -58.67 -49.0 95.82 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.919 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.0 Cg_endo -61.17 -36.42 80.86 Favored 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.257 1.971 . . . . 0.0 112.402 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.03 -26.38 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.79 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.0 tt -80.07 -40.22 28.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.83 0.287 . . . . 0.0 111.526 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.409 ' CG1' ' H ' ' A' ' 29' ' ' ILE . 7.2 p -58.93 -52.01 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' H ' ' CG1' ' A' ' 28' ' ' VAL . 20.7 tt -61.84 -32.46 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.21 0.529 . . . . 0.0 110.044 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -43.29 87.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.061 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.7 -38.15 90.01 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.382 1.087 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.01 -44.52 98.1 Favored Glycine 0 CA--C 1.549 2.209 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.664 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -66.61 -47.04 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.093 0.446 . . . . 0.0 110.946 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 37' ' ' SER . 31.6 m -70.79 -32.05 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.661 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.83 -52.04 55.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.41 -34.44 77.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.974 0.416 . . . . 0.0 110.157 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 16.5 p -59.86 -19.37 50.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.614 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.6 -36.51 71.84 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.039 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.7 tp -45.48 -23.01 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.62 11.98 26.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.547 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.93 152.0 22.62 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.71 147.18 45.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -44.31 -45.03 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.285 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 65.8 t0 -89.61 -30.61 18.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 122.553 1.168 . . . . 0.0 114.146 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -86.62 -0.88 57.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.477 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.38 1.61 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 119.106 0.866 . . . . 0.0 110.129 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.12 -32.79 26.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mp -51.86 -52.26 62.95 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.67 -35.55 3.43 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.18 1.253 . . . . 0.0 111.105 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.45 10.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.884 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -66.72 -36.71 83.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.635 0.255 . . . . 0.0 110.601 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.26 -27.25 63.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.049 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.32 -42.96 97.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 85.1 m-85 -60.39 -32.72 71.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.882 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.43 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 1.7 mp -64.96 -42.08 93.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.4 -42.73 97.63 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.4 mt -70.86 -32.49 69.51 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.717 -0.284 . . . . 0.0 110.772 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 22.1 m -56.41 -57.97 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.752 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.55 -29.02 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 120.928 0.394 . . . . 0.0 111.156 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -63.98 -28.42 69.8 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.68 77.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.954 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 62' ' ' ILE . 14.2 tt -68.14 -23.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.346 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.11 -49.41 67.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.343 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -49.39 -32.04 10.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.922 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.42 -54.79 6.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.822 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -61.99 -45.11 95.06 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.553 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 26.2 mt-30 -65.91 -30.24 70.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.136 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.779 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -47.81 -38.26 15.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.27 -32.87 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.93 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.99 61.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.84 -45.23 95.33 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.595 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.2 p -72.29 -26.01 61.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.99 0.424 . . . . 0.0 110.609 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.2 -22.62 64.92 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.945 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -89.76 -9.06 50.73 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.255 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 16.8 m -58.59 -48.3 97.15 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 24' ' ' THR . 33.4 Cg_endo -61.35 -37.96 68.46 Favored 'Trans proline' 0 N--CA 1.513 2.634 0 C-N-CA 122.314 2.009 . . . . 0.0 112.54 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.45 -26.33 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.865 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.9 tt -79.17 -40.54 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.91 0.323 . . . . 0.0 111.657 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.92 -52.12 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.21 -32.66 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.512 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -44.34 85.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.572 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.34 -38.87 92.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.269 1.033 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.64 -43.65 86.21 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.782 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.21 -44.42 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.6 -35.55 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.592 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.7 -51.8 56.84 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.67 -32.83 73.03 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 40' ' ' THR . 5.4 m -58.36 -18.51 28.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.04 79.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.13 0.491 . . . . 0.0 109.998 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.2 mm? -52.42 -25.14 9.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.132 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 37' ' ' SER . 43.5 p -95.84 8.89 42.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.074 0.464 . . . . 0.0 110.155 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.79 152.02 22.76 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -73.48 146.48 44.9 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -44.62 -45.24 9.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.503 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.84 -30.61 18.82 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -86.79 -0.7 56.87 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.46 2.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 119.079 0.854 . . . . 0.0 109.77 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.02 -32.55 26.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 111.278 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -51.23 -52.6 57.43 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.162 -177.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.4 Cg_endo -73.65 -35.5 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.056 1.17 . . . . 0.0 110.927 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.75 -53.71 9.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.966 -174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 10.8 mp -67.13 -35.81 80.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.113 0.483 . . . . 0.0 110.617 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.39 -28.85 70.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.297 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.95 -43.74 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.543 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -61.84 -32.68 73.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' O ' ' OG1' ' A' ' 58' ' ' THR . 95.9 mt -63.83 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.441 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.87 -42.89 99.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.989 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.92 -35.64 67.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.921 0.361 . . . . 0.0 111.566 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' A' ' 59' ' ' ILE . 29.9 p -54.41 -59.72 4.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.909 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.52 ' H ' ' HG1' ' A' ' 58' ' ' THR . 77.9 mt -59.99 -29.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.76 -27.55 69.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.197 0.522 . . . . 0.0 112.184 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.59 98.57 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.608 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.25 -22.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.8 -47.88 70.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.426 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -51.27 -36.94 44.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.167 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.3 -54.54 6.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.625 0.726 . . . . 0.0 110.967 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.14 -45.0 96.46 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.559 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.39 -30.67 71.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.779 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.468 179.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.559 0.219 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 17' ' ' LEU 0.255 4.2 mm? -49.11 -40.17 31.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.956 0.502 . . . . 0.0 111.769 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.31 -32.5 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.843 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -72.73 -20.14 61.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.621 0.248 . . . . 0.0 111.661 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.04 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.923 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.0 p -70.09 -26.31 63.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.973 0.416 . . . . 0.0 110.928 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 40.9 p -60.9 -22.59 64.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.624 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' LEU . 98.0 m-85 -87.94 -9.67 52.87 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.248 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 m -57.79 -48.26 97.48 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.372 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.4 Cg_endo -60.37 -40.73 55.64 Favored 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.444 2.096 . . . . 0.0 112.75 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.92 -27.13 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' PHE . 57.2 tp -76.54 -40.44 49.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 29' ' ' ILE . 9.1 p -59.41 -50.72 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.456 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 64.5 mt -60.53 -35.84 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tt -53.43 -44.94 69.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.262 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.87 -38.95 92.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.121 0.962 . . . . 0.0 111.3 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.8 70.76 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.411 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.74 -43.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 37' ' ' SER . 97.2 t -62.68 -42.04 94.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.942 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.72 -52.36 46.37 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.84 -33.93 76.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 9.0 p -59.93 -18.9 48.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.72 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.943 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -50.81 -25.75 4.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.24 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 37' ' ' SER . 50.0 p -96.33 8.98 42.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 150.99 22.09 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.15 148.16 41.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.669 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 tp -43.8 -45.67 7.42 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.176 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.16 -29.69 20.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.2 -0.26 56.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.792 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.45 0.14 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 CA-C-N 119.366 0.984 . . . . 0.0 110.382 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.41 -32.38 24.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.228 0.537 . . . . 0.0 111.503 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.57 -52.08 63.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.172 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.64 -36.39 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.061 1.174 . . . . 0.0 110.932 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.6 7.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.579 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.05 -36.45 82.06 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.461 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -62.96 -28.34 70.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.316 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.34 -44.65 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.349 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.43 -34.86 78.89 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 52' ' ' ALA . 15.9 tt -65.76 -37.34 79.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.24 98.28 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.99 -31.88 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.559 0.218 . . . . 0.0 110.543 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 m -57.18 -57.87 10.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.792 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.008 0.432 . . . . 0.0 111.405 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 49.7 t80 -61.96 -27.34 68.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.13 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.42 99.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.615 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.28 -22.0 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -65.94 -46.94 76.36 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -49.85 -35.1 21.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.26 -37.72 66.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.538 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -72.15 -43.73 64.19 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -50.54 -44.14 56.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.255 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.141 179.402 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 17' ' ' LEU . 65.9 p . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 16' ' ' THR . 47.0 tp -56.26 -43.29 78.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.531 0.605 . . . . 0.0 111.955 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.03 -33.8 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 0.0 111.131 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -71.19 -19.14 62.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.535 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.09 -46.06 90.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.715 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.4 t -75.35 -26.08 58.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 110.881 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 57.7 p -61.1 -21.87 64.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.772 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 27' ' ' LEU . 55.8 m-85 -89.54 -9.08 51.22 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.195 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.566 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -58.19 -48.23 97.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.262 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 24' ' ' THR . 37.2 Cg_endo -62.5 -34.95 74.14 Favored 'Trans proline' 0 N--CA 1.51 2.459 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -85.29 -26.13 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.308 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.5 tp -77.71 -40.35 41.54 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.137 -0.352 . . . . 0.0 111.35 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 29' ' ' ILE . 7.9 p -60.03 -52.2 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.495 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 20.9 pt -62.78 -37.74 79.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.88 -44.35 74.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.826 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.23 -37.68 88.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.061 0.934 . . . . 0.0 111.274 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.29 -43.75 75.41 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.709 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.22 -43.79 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.43 ' O ' ' OG ' ' A' ' 37' ' ' SER . 92.1 t -61.65 -34.09 60.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.429 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.32 -51.83 56.37 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.863 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.24 -32.93 73.67 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 8.4 p -58.62 -18.52 31.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.79 -36.83 77.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 109.951 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -25.48 36.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.429 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 37' ' ' SER . 72.1 p -95.48 8.76 42.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.52 151.11 22.28 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.78 147.89 43.02 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 tt -44.87 -46.21 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.644 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.02 -30.03 20.27 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.784 -1.197 . . . . 0.0 114.156 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -87.47 -0.9 57.48 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.391 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.16 -0.68 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 110.44 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.6 tp -84.24 -33.37 24.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.547 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.92 -52.52 60.67 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 58.6 Cg_endo -73.71 -37.53 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.053 1.169 . . . . 0.0 111.123 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -44.12 -52.23 7.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.561 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.07 -35.82 81.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.085 0.469 . . . . 0.0 110.539 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.97 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.872 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 49' ' ' PRO . 35.1 mm -64.42 -44.21 97.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.259 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 58' ' ' THR . 88.6 m-85 -62.1 -33.44 74.44 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.14 -42.36 95.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.78 -42.37 98.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.445 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -70.87 -31.98 68.83 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.69 -0.3 . . . . 0.0 110.549 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 21.0 m -56.62 -58.73 6.81 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.269 -0.973 . . . . 0.0 108.783 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.99 -28.09 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 CA-C-O 121.436 0.636 . . . . 0.0 111.172 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -65.3 -29.19 69.93 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.493 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.44 84.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.351 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.74 -21.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -66.38 -50.38 63.68 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.048 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -49.29 -34.38 15.29 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -77.51 -55.32 5.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.696 0.76 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -60.09 -45.35 93.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.405 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -64.92 -30.47 71.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.104 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mm . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -54.55 -32.75 53.55 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.78 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.6 m -59.59 -47.06 87.05 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 m -57.16 -48.83 77.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.976 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.3 -29.73 67.66 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.033 0.444 . . . . 0.0 110.508 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 14' ' ' GLY . 42.8 t -60.85 -47.92 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.466 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.61 65.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.53 -30.48 71.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.037 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 24' ' ' THR . 9.2 t -50.71 -19.83 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.034 0.533 . . . . 0.0 111.004 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.1 p -58.93 -21.23 57.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -87.48 -8.34 56.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.648 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.492 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.6 m -60.62 -48.62 92.82 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.736 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 24' ' ' THR . 32.2 Cg_endo -60.71 -40.28 56.28 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 121.512 1.475 . . . . 0.0 111.55 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -75.12 -25.78 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.688 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.1 tp -73.18 -37.52 66.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.887 -0.508 . . . . 0.0 110.584 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.9 -50.08 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.403 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.15 -32.01 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.149 0.499 . . . . 0.0 110.432 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -45.06 77.39 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.207 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.55 -38.21 90.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.32 1.057 . . . . 0.0 111.133 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.1 -43.43 88.56 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.771 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.2 t -61.38 -44.32 98.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.89 -34.52 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.07 -51.09 60.42 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.17 -32.53 71.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -59.21 -18.56 37.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.859 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.36 -37.54 72.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 109.759 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -49.18 -24.58 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.592 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -95.58 10.99 34.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.125 0.488 . . . . 0.0 110.294 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.23 151.33 21.95 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.41 145.78 43.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.735 -0.274 . . . . 0.0 111.103 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.6 tp -44.36 -42.33 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.945 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 64.5 t0 -88.39 -30.27 19.62 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -88.96 0.4 56.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.677 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 9.2 p -101.91 -1.09 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.792 1.178 . . . . 0.0 109.931 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.81 -35.17 20.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.23 0.538 . . . . 0.0 111.892 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -52.58 1.19 Allowed Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.21 -34.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.994 2.462 . . . . 0.0 115.176 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -70.72 -48.82 52.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.312 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 tp -71.28 -27.38 63.38 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.18 63.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 4.0 pt -63.02 -40.95 90.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.978 0.418 . . . . 0.0 110.803 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 76.0 t80 -59.77 -36.27 76.33 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.727 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 55' ' ' ILE . 40.0 mm -64.17 -42.56 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.47 -41.5 97.14 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.2 mt -72.66 -32.57 65.93 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.798 -0.236 . . . . 0.0 110.707 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 m -55.28 -57.68 10.82 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.599 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.38 -30.11 48.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 45.0 t80 -62.86 -28.01 69.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.13 91.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.481 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.77 -22.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -66.6 -47.47 72.59 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -54.23 -40.35 67.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 0.0 111.557 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -70.34 -40.31 74.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.821 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -69.4 -44.85 70.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.159 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ALA . 11.7 tp-100 -49.82 -46.15 50.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' ALA . . . 31.37 65.62 0.17 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 98.4 m-20 54.43 -80.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 68' ' ' ALA . . . 79.4 -148.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.5 m -60.09 -41.83 93.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.593 -179.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.489 ' O ' ' OG1' ' A' ' 16' ' ' THR . 20.8 tt . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -53.99 -34.22 51.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.296 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 p -59.7 -48.9 79.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.267 1.033 . . . . 0.0 108.371 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.641 ' HG1' ' N ' ' A' ' 17' ' ' LEU . 25.9 p -54.93 -47.3 74.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.528 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.641 ' N ' ' HG1' ' A' ' 16' ' ' THR . 10.9 mp -71.45 -29.9 65.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.028 0.442 . . . . 0.0 110.91 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 14' ' ' GLY . 26.3 t -60.33 -48.75 86.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.0 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.82 -24.62 65.31 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.336 0.588 . . . . 0.0 110.602 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.1 tp -62.31 -30.35 71.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.911 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.598 ' O ' ' OG1' ' A' ' 24' ' ' THR . 32.5 t -50.89 -19.52 1.03 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -57.53 -20.54 32.39 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.384 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 26' ' ' VAL . 55.7 m-85 -86.14 -10.83 54.08 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.734 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 21' ' ' SER . 2.2 p -55.88 -49.08 95.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.394 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -58.37 -43.27 47.74 Favored 'Trans proline' 0 N--CA 1.511 2.501 0 C-N-CA 122.408 2.072 . . . . 0.0 113.012 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -76.34 -25.34 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.089 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.42 -38.18 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.517 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.82 -51.64 70.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.982 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 29' ' ' ILE . 94.3 mt -63.97 -42.58 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -53.13 -45.09 68.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.36 -37.25 86.47 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.19 0.995 . . . . 0.0 111.452 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.73 -42.99 69.21 Favored Glycine 0 CA--C 1.543 1.811 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.134 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -57.75 -33.72 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.13 -39.32 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.04 -51.51 53.37 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 119.192 -1.48 . . . . 0.0 109.542 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.46 -32.13 69.96 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.995 0.426 . . . . 0.0 110.038 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t -57.32 -17.85 14.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.51 -38.84 75.31 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -48.25 -25.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.917 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 m -96.2 9.82 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 110.436 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.87 150.74 21.76 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.09 146.68 43.42 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.262 -0.175 . . . . 0.0 110.77 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.8 tp -43.86 -43.5 6.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.771 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 37.7 p30 -89.02 -29.85 19.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.1 t80 -88.35 0.29 56.34 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.671 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 6.7 p -100.02 0.44 10.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-N 119.56 1.073 . . . . 0.0 109.839 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -85.67 -34.93 21.19 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.151 -0.968 . . . . 0.0 112.379 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 -52.19 1.22 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' CD ' ' H ' ' A' ' 50' ' ' ALA . 82.8 Cg_endo -91.62 -34.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.492 2.128 . . . . 0.0 114.967 -177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -70.51 -50.4 38.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.239 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 tp -70.59 -27.26 63.97 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.935 0.397 . . . . 0.0 111.043 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.46 65.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.896 0.379 . . . . 0.0 111.672 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.91 -33.17 71.51 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.47 -42.33 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.61 98.26 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.486 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -32.09 68.52 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.863 -0.198 . . . . 0.0 110.664 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -56.33 -58.35 8.38 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.172 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.02 -27.71 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.078 0.466 . . . . 0.0 110.778 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -66.16 -29.39 69.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.53 83.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.381 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 pt -70.64 -21.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.84 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -66.28 -49.19 67.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -49.31 -31.54 9.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.709 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -76.33 -54.29 6.97 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.93 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.25 -44.09 95.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.119 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.33 -38.45 63.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -71.16 -42.48 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 53.19 92.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.352 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.1 m -70.22 148.97 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.595 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.579 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' OG1' ' A' ' 16' ' ' THR . 96.6 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -53.89 -37.57 58.09 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.552 ' HG1' ' H ' ' A' ' 16' ' ' THR . 19.0 p -59.18 -48.98 79.62 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.313 1.054 . . . . 0.0 108.95 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.552 ' H ' ' HG1' ' A' ' 15' ' ' THR . 16.2 p -55.73 -48.02 75.91 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.754 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.25 -28.8 64.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.294 0.568 . . . . 0.0 110.732 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 14' ' ' GLY . 20.0 t -60.1 -46.14 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.847 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.74 65.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.478 0.656 . . . . 0.0 110.898 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.54 -29.62 68.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.039 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 34.0 t -52.21 -21.33 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.685 0.279 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.2 m -59.27 -20.5 54.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LEU . 72.6 m-85 -89.87 -10.04 46.77 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.567 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.622 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 m -56.66 -48.06 97.88 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 24' ' ' THR . 34.2 Cg_endo -61.96 -37.05 68.24 Favored 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 122.372 2.048 . . . . 0.0 111.938 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.01 -26.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.939 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 23' ' ' PHE . 52.2 tp -77.24 -40.63 44.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.659 0.266 . . . . 0.0 111.517 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 29' ' ' ILE . 7.7 p -60.42 -52.33 62.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.792 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' H ' ' CG1' ' A' ' 28' ' ' VAL . 10.4 tp -64.09 -39.07 84.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 109.659 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.2 tp -52.8 -44.27 66.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.555 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.93 -34.26 77.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.963 0.887 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.48 -42.09 74.61 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.289 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.49 -32.02 35.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' ' OG ' ' A' ' 37' ' ' SER . 41.0 t -63.06 -33.23 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -51.24 60.03 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.55 -29.06 58.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 4.0 p -55.56 -17.16 4.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.934 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.29 -38.79 77.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mp -49.68 -23.8 1.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.786 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 37' ' ' SER . 30.4 p -94.57 11.17 31.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.299 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.95 154.66 24.76 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 46' ' ' VAL . 1.1 t80 -73.5 147.79 43.73 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.632 -0.334 . . . . 0.0 110.268 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -44.57 -44.25 8.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.44 -0.315 . . . . 0.0 110.416 -176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 47.0 p-10 -88.94 -30.36 18.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 8.3 t80 -88.69 1.24 55.46 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.312 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 8.3 p -100.26 1.02 10.48 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-N 119.493 1.042 . . . . 0.0 110.701 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.87 -31.88 23.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.635 0.731 . . . . 0.0 112.797 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.29 -51.58 13.26 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.432 -178.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 72.7 Cg_endo -83.84 -26.5 1.97 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 123.565 2.844 . . . . 0.0 113.465 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -68.95 -50.52 48.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.562 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.29 -27.66 64.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.052 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.2 -29.31 67.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 111.574 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 53' ' ' ILE . 34.2 mm -65.93 -43.65 92.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.174 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' O ' ' OG1' ' A' ' 58' ' ' THR . 78.0 m-85 -62.24 -32.65 73.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.39 -41.86 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.81 -41.97 97.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.862 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 3.9 mm? -73.06 -31.37 64.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 25.3 m -56.68 -59.36 5.12 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.583 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.21 -27.47 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.76 -27.1 69.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.742 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.76 97.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.222 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.6 mt -68.35 -21.99 26.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -66.99 -48.01 69.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -49.41 -34.46 16.43 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.898 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -77.18 -55.7 5.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.885 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -59.94 -44.0 94.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.839 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -55.47 -38.52 69.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.733 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.11 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -177.04 67.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.603 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -47.88 148.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 0.0 110.55 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -70.34 144.36 51.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.577 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' OG1' ' A' ' 16' ' ' THR . 96.6 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -53.01 -37.63 54.2 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -59.32 -47.1 86.69 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.058 0.933 . . . . 0.0 109.347 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 17.6 p -56.81 -48.38 78.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.948 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.09 -29.05 64.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.184 0.516 . . . . 0.0 110.941 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 14' ' ' GLY . 23.1 t -60.25 -47.48 92.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.735 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.82 66.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.573 0.701 . . . . 0.0 110.768 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.69 -28.62 68.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.4 p -51.69 -20.95 2.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.175 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 m -58.35 -19.97 39.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 27' ' ' LEU . 69.9 m-85 -89.59 -10.48 45.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.65 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.633 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 6.6 m -55.5 -48.87 95.41 Favored Pre-proline 0 CA--C 1.528 0.125 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -60.98 -36.48 82.61 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.786 2.324 . . . . 0.0 111.558 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -79.13 -25.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.899 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' PHE . 55.5 tp -74.19 -39.56 63.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.019 0.438 . . . . 0.0 112.122 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 29' ' ' ILE . 3.9 m -60.61 -52.05 65.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' H ' HG23 ' A' ' 28' ' ' VAL . 22.4 pt -63.79 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.93 -43.93 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.357 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.3 -34.68 78.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.94 0.876 . . . . 0.0 111.067 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.68 94.49 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.91 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.4 -47.42 86.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.3 -31.83 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.821 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.53 -52.3 52.66 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.196 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 97.9 mt -55.51 -29.13 58.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -54.59 -15.7 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.017 0.823 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.84 -40.37 84.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 111.716 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -44.02 -23.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.535 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m -93.73 11.72 28.11 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.679 0.752 . . . . 0.0 109.48 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.71 152.93 22.8 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.37 146.59 42.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.544 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' H ' ' CD1' ' A' ' 43' ' ' LEU . 11.0 mp -43.82 -44.92 7.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.373 -0.204 . . . . 0.0 111.498 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 66.4 t0 -88.74 -31.3 18.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.92 2.69 50.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.188 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 9.9 p -101.95 0.78 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.151 0.887 . . . . 0.0 110.384 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.05 -34.68 17.89 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.049 -1.032 . . . . 0.0 112.912 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -79.42 -53.02 1.09 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.007 -177.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' H ' ' A' ' 50' ' ' ALA . 73.8 Cg_endo -90.29 -35.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 122.424 2.083 . . . . 0.0 113.919 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -72.02 -51.93 19.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.249 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.5 -28.02 67.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.892 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.54 -28.05 65.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.402 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.96 -43.76 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.532 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -61.56 -32.21 72.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.627 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -63.62 -41.39 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.53 96.72 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.64 -31.4 65.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -56.68 -60.38 3.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.555 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.85 -27.96 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-O 120.863 0.363 . . . . 0.0 110.527 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.433 ' HH ' HG23 ' A' ' 24' ' ' THR . 36.7 t80 -62.04 -27.14 68.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.164 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.38 97.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.357 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.96 -21.96 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.69 -46.38 75.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -49.52 -30.16 7.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.193 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.11 -56.74 4.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 79.1 mtp85 -58.97 -44.63 91.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.247 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.37 -30.18 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.38 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.4 39.64 0.47 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 66' ' ' ARG . 5.4 p30 -171.52 -176.64 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.242 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' SER . . . 63.62 -81.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.695 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 p 43.05 18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ALA . 13.9 t . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.555 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 13' ' ' ILE . 96.6 mt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -53.86 -35.18 52.65 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.9 m -60.28 -47.78 84.53 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -56.6 -48.59 77.09 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.245 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.09 -30.39 68.69 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.217 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 14' ' ' GLY . 27.2 t -60.17 -47.38 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.341 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.08 66.79 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -30.26 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.015 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 24' ' ' THR . 8.2 m -50.31 -20.18 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.859 0.464 . . . . 0.0 110.7 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 6.4 m -57.87 -19.7 31.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -88.09 -10.74 49.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.82 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -58.78 -43.67 98.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.29 -177.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 37.8 Cg_exo -63.15 -43.22 19.65 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.011 2.474 . . . . 0.0 111.212 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.28 -25.65 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.35 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.6 tt -72.58 -38.02 68.0 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.933 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.49 -51.25 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.107 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.57 -35.06 73.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.44 -44.1 80.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.555 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.9 -36.9 85.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.55 1.166 . . . . 0.0 110.797 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.78 76.84 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.908 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.22 -34.86 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.86 -35.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.302 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.49 -51.79 56.7 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.28 -33.34 74.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.5 m -58.91 -18.8 36.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.741 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.57 79.67 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 109.968 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -25.53 25.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.1 6.98 47.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.147 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.07 155.21 24.29 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.02 145.81 44.24 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.736 -0.273 . . . . 0.0 111.247 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 tp -43.03 -41.64 3.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.644 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -87.57 -27.43 22.57 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -86.04 1.32 50.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.067 -1.424 . . . . 0.0 113.184 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -96.76 1.06 10.52 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.026 0 CA-C-N 119.738 1.154 . . . . 0.0 110.614 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 mt -83.38 -32.56 26.12 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 111.437 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.59 -52.12 63.25 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.158 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.74 -36.89 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.27 1.313 . . . . 0.0 110.992 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.41 -53.93 8.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.835 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.54 -37.07 82.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.871 -0.518 . . . . 0.0 110.943 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.96 71.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.441 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.89 -44.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.924 0.392 . . . . 0.0 110.97 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 59.0 t80 -64.47 -36.78 85.29 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.152 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.97 -42.87 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.99 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.54 -42.58 99.69 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.618 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.868 0.334 . . . . 0.0 110.635 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 53.5 m -55.8 -58.83 6.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.449 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.71 -29.17 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.61 -29.17 70.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.16 80.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.193 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 62' ' ' ILE . 37.8 mm -68.6 -22.59 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.877 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -66.88 -49.52 65.36 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.685 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -54.34 -41.23 68.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.442 0.639 . . . . 0.0 111.333 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.15 -40.36 71.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.624 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -71.07 -45.63 63.41 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.382 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.544 ' C ' ' H ' ' A' ' 69' ' ' ASP . 57.3 tt0 -50.26 -49.94 51.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 69' ' ' ASP . . . 64.91 -40.92 0.29 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.405 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 67' ' ' GLN . 2.0 m-20 176.6 -68.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.15 121.89 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.9 t -62.28 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.686 -179.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 13' ' ' ILE . 28.2 mm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.88 -42.96 5.54 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-O 122.14 0.856 . . . . 0.0 113.519 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.6 p -59.46 -48.75 80.44 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.79 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -50.39 8.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.632 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.25 52.2 tp -47.29 -35.0 7.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.86 -32.77 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.874 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -74.04 -20.27 60.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.788 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.86 -46.85 88.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.158 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -75.59 -25.86 57.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 110.097 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -61.37 -21.87 64.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.407 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 70.8 m-85 -87.38 -8.12 56.96 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.304 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.506 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m -61.85 -49.38 86.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.479 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 24' ' ' THR . 27.6 Cg_endo -59.93 -41.6 52.11 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.429 1.419 . . . . 0.0 111.26 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.87 -25.99 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.598 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.1 tt -71.76 -37.34 70.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.292 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.53 -50.18 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.13 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.42 -36.91 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.113 0.483 . . . . 0.0 109.702 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.12 -46.35 65.31 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.67 -37.8 88.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.146 0.974 . . . . 0.0 111.484 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.14 -43.83 93.3 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.921 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.36 -44.39 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.23 -38.19 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.6 -51.7 54.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.65 -34.0 74.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.193 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -58.19 -18.2 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.18 81.66 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.91 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 tp -50.71 -25.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.34 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -95.86 9.87 39.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.54 22.62 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 147.3 44.39 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.686 -0.302 . . . . 0.0 110.614 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 mt -44.86 -44.91 9.93 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.338 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.74 -30.3 19.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -88.0 -0.68 57.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.298 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.3 2.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 119.301 0.955 . . . . 0.0 110.204 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.87 -32.69 27.28 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 110.607 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.2 mp -51.72 -52.89 56.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.922 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.5 Cg_endo -73.88 -36.02 3.9 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.052 1.168 . . . . 0.0 111.583 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.13 -53.53 10.23 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.158 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 10.8 mp -66.16 -35.38 80.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.19 0.45 . . . . 0.0 110.297 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.4 70.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.454 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.97 -43.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.48 -34.43 77.74 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.36 -42.31 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.5 97.99 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.442 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -73.43 -32.03 64.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.5 m -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.743 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.5 -29.48 46.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.19 -27.42 68.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.23 0.538 . . . . 0.0 112.235 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.63 -44.12 97.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.497 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 62' ' ' ILE . 96.5 mt -69.6 -22.35 25.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.454 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -67.04 -47.56 71.0 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.369 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -50.76 -37.66 43.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.326 0.584 . . . . 0.0 110.958 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -71.46 -43.98 65.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.768 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -70.36 -46.62 63.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.215 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' ASP . 99.3 mm-40 -61.7 -29.98 70.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.741 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.65 46.37 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.785 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' GLN . 67.9 t0 -79.61 -109.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.518 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 67.29 -57.91 0.42 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.88 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -149.33 148.55 29.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.642 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 14' ' ' GLY . 20.3 tt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 13' ' ' ILE . . . -84.48 -41.03 8.04 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.97 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 19' ' ' ALA . 96.2 m -60.5 -48.0 83.69 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.433 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 p -59.7 -61.75 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 117.713 -1.595 . . . . 0.0 111.977 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -54.39 -43.67 71.61 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.616 0.644 . . . . 0.0 111.823 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.79 -32.5 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.14 -42.71 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.776 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -74.27 -26.24 60.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.342 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 52.5 p -61.38 -22.73 65.23 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 27' ' ' LEU . 84.2 m-85 -87.42 -9.38 54.84 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.671 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.54 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 3.1 m -58.67 -49.0 95.82 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.919 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.0 Cg_endo -61.17 -36.42 80.86 Favored 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.257 1.971 . . . . 0.0 112.402 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.03 -26.38 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.79 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.0 tt -80.07 -40.22 28.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.83 0.287 . . . . 0.0 111.526 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.409 ' CG1' ' H ' ' A' ' 29' ' ' ILE . 7.2 p -58.93 -52.01 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' H ' ' CG1' ' A' ' 28' ' ' VAL . 20.7 tt -61.84 -32.46 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.21 0.529 . . . . 0.0 110.044 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -43.29 87.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.061 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.7 -38.15 90.01 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.382 1.087 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.01 -44.52 98.1 Favored Glycine 0 CA--C 1.549 2.209 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.664 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -66.61 -47.04 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.093 0.446 . . . . 0.0 110.946 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 37' ' ' SER . 31.6 m -70.79 -32.05 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.661 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.83 -52.04 55.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.41 -34.44 77.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.974 0.416 . . . . 0.0 110.157 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 16.5 p -59.86 -19.37 50.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.614 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.6 -36.51 71.84 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.039 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.7 tp -45.48 -23.01 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.62 11.98 26.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.547 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.93 152.0 22.62 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.71 147.18 45.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -44.31 -45.03 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.285 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 65.8 t0 -89.61 -30.61 18.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 122.553 1.168 . . . . 0.0 114.146 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -86.62 -0.88 57.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.477 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.38 1.61 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 119.106 0.866 . . . . 0.0 110.129 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.12 -32.79 26.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mp -51.86 -52.26 62.95 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.67 -35.55 3.43 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.18 1.253 . . . . 0.0 111.105 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.45 10.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.884 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -66.72 -36.71 83.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.635 0.255 . . . . 0.0 110.601 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.26 -27.25 63.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.049 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.32 -42.96 97.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 85.1 m-85 -60.39 -32.72 71.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.882 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.43 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 1.7 mp -64.96 -42.08 93.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.4 -42.73 97.63 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.4 mt -70.86 -32.49 69.51 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.717 -0.284 . . . . 0.0 110.772 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 22.1 m -56.41 -57.97 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.752 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.55 -29.02 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 120.928 0.394 . . . . 0.0 111.156 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -63.98 -28.42 69.8 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.68 77.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.954 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 62' ' ' ILE . 14.2 tt -68.14 -23.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.346 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.11 -49.41 67.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.343 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -49.39 -32.04 10.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.922 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.42 -54.79 6.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.822 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -61.99 -45.11 95.06 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.553 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 26.2 mt-30 -65.91 -30.24 70.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.136 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . 35.1 86.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.779 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -62.65 -41.32 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.67 33.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.536 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -65.78 145.17 56.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.688 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.494 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 13' ' ' ILE . 96.3 mt . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.28 -42.22 5.29 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.227 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 m -60.78 -50.03 75.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.888 -1.156 . . . . 0.0 112.721 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -78.37 -50.29 12.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.789 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -47.81 -38.26 15.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.27 -32.87 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.93 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.99 61.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.84 -45.23 95.33 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.595 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.2 p -72.29 -26.01 61.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.99 0.424 . . . . 0.0 110.609 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.2 -22.62 64.92 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.945 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -89.76 -9.06 50.73 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.255 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 16.8 m -58.59 -48.3 97.15 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 24' ' ' THR . 33.4 Cg_endo -61.35 -37.96 68.46 Favored 'Trans proline' 0 N--CA 1.513 2.634 0 C-N-CA 122.314 2.009 . . . . 0.0 112.54 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.45 -26.33 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.865 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.9 tt -79.17 -40.54 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.91 0.323 . . . . 0.0 111.657 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.92 -52.12 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.21 -32.66 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.512 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.71 -44.34 85.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.572 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.34 -38.87 92.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.269 1.033 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.64 -43.65 86.21 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.782 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.21 -44.42 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.6 -35.55 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.592 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.7 -51.8 56.84 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.67 -32.83 73.03 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 40' ' ' THR . 5.4 m -58.36 -18.51 28.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.04 79.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.13 0.491 . . . . 0.0 109.998 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.2 mm? -52.42 -25.14 9.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.132 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 37' ' ' SER . 43.5 p -95.84 8.89 42.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.074 0.464 . . . . 0.0 110.155 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.79 152.02 22.76 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -73.48 146.48 44.9 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -44.62 -45.24 9.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.503 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.84 -30.61 18.82 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -86.79 -0.7 56.87 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.46 2.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 119.079 0.854 . . . . 0.0 109.77 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.02 -32.55 26.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 111.278 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -51.23 -52.6 57.43 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.162 -177.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.4 Cg_endo -73.65 -35.5 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.056 1.17 . . . . 0.0 110.927 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.75 -53.71 9.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.966 -174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 10.8 mp -67.13 -35.81 80.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.113 0.483 . . . . 0.0 110.617 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.39 -28.85 70.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.297 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.95 -43.74 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.543 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -61.84 -32.68 73.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.361 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' O ' ' OG1' ' A' ' 58' ' ' THR . 95.9 mt -63.83 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.441 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.87 -42.89 99.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.989 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.92 -35.64 67.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.921 0.361 . . . . 0.0 111.566 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' A' ' 59' ' ' ILE . 29.9 p -54.41 -59.72 4.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.909 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.52 ' H ' ' HG1' ' A' ' 58' ' ' THR . 77.9 mt -59.99 -29.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.76 -27.55 69.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.197 0.522 . . . . 0.0 112.184 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.59 98.57 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.608 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.25 -22.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.8 -47.88 70.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.426 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -51.27 -36.94 44.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.167 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.3 -54.54 6.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.625 0.726 . . . . 0.0 110.967 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.14 -45.0 96.46 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.559 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 69' ' ' ASP . 68.8 tp60 -63.39 -30.67 71.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.779 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 43.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.468 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 67' ' ' GLN . 62.1 t0 48.06 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.694 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.13 147.59 39.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.603 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -69.85 147.46 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.599 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.9 -40.05 5.66 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-O 122.021 0.789 . . . . 0.0 113.324 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.4 m -60.12 -48.05 83.33 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.908 -1.146 . . . . 0.0 113.438 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -81.11 -49.68 10.56 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 118.889 -1.125 . . . . 0.0 111.292 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 17' ' ' LEU 0.255 4.2 mm? -49.11 -40.17 31.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.956 0.502 . . . . 0.0 111.769 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.31 -32.5 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.843 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -72.73 -20.14 61.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.621 0.248 . . . . 0.0 111.661 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.04 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.923 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.0 p -70.09 -26.31 63.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.973 0.416 . . . . 0.0 110.928 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 40.9 p -60.9 -22.59 64.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.624 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' LEU . 98.0 m-85 -87.94 -9.67 52.87 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.248 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 m -57.79 -48.26 97.48 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.372 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.4 Cg_endo -60.37 -40.73 55.64 Favored 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.444 2.096 . . . . 0.0 112.75 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.92 -27.13 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' PHE . 57.2 tp -76.54 -40.44 49.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 29' ' ' ILE . 9.1 p -59.41 -50.72 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.456 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 64.5 mt -60.53 -35.84 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tt -53.43 -44.94 69.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.262 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.87 -38.95 92.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.121 0.962 . . . . 0.0 111.3 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.8 70.76 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.411 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.74 -43.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 37' ' ' SER . 97.2 t -62.68 -42.04 94.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.942 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.72 -52.36 46.37 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.84 -33.93 76.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 9.0 p -59.93 -18.9 48.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.72 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.943 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -50.81 -25.75 4.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.24 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 37' ' ' SER . 50.0 p -96.33 8.98 42.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 150.99 22.09 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.15 148.16 41.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.669 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 tp -43.8 -45.67 7.42 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.176 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.16 -29.69 20.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.2 -0.26 56.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.792 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.45 0.14 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 CA-C-N 119.366 0.984 . . . . 0.0 110.382 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.41 -32.38 24.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.228 0.537 . . . . 0.0 111.503 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.57 -52.08 63.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.172 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.64 -36.39 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.061 1.174 . . . . 0.0 110.932 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.6 7.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.579 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.05 -36.45 82.06 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.461 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -62.96 -28.34 70.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.316 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.34 -44.65 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.349 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.43 -34.86 78.89 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 52' ' ' ALA . 15.9 tt -65.76 -37.34 79.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.24 98.28 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.99 -31.88 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.559 0.218 . . . . 0.0 110.543 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 m -57.18 -57.87 10.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.792 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.008 0.432 . . . . 0.0 111.405 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 49.7 t80 -61.96 -27.34 68.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.13 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.42 99.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.615 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.28 -22.0 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -65.94 -46.94 76.36 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -49.85 -35.1 21.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.26 -37.72 66.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.538 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -72.15 -43.73 64.19 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.54 ' C ' ' H ' ' A' ' 69' ' ' ASP . 87.9 mt-30 -50.54 -44.14 56.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.255 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 67.28 -39.38 0.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.141 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 67' ' ' GLN . 98.4 m-20 57.05 33.86 24.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.876 0.37 . . . . 0.0 110.413 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' SER . . . -64.03 -38.44 91.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 71' ' ' SER . 23.8 p 44.23 96.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.6 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.59 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 -40.55 8.29 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.938 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -59.36 -48.06 83.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.436 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 17' ' ' LEU . 65.9 p -59.47 -61.55 2.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 117.597 -1.641 . . . . 0.0 111.989 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 16' ' ' THR . 47.0 tp -56.26 -43.29 78.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.531 0.605 . . . . 0.0 111.955 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.03 -33.8 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 0.0 111.131 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -71.19 -19.14 62.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.535 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.09 -46.06 90.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.715 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.4 t -75.35 -26.08 58.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 110.881 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 57.7 p -61.1 -21.87 64.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.772 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 27' ' ' LEU . 55.8 m-85 -89.54 -9.08 51.22 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.195 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.566 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -58.19 -48.23 97.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.262 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 24' ' ' THR . 37.2 Cg_endo -62.5 -34.95 74.14 Favored 'Trans proline' 0 N--CA 1.51 2.459 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -85.29 -26.13 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.308 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.5 tp -77.71 -40.35 41.54 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.137 -0.352 . . . . 0.0 111.35 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 29' ' ' ILE . 7.9 p -60.03 -52.2 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.495 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 20.9 pt -62.78 -37.74 79.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.88 -44.35 74.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.826 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.23 -37.68 88.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.061 0.934 . . . . 0.0 111.274 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.29 -43.75 75.41 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.709 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.22 -43.79 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.43 ' O ' ' OG ' ' A' ' 37' ' ' SER . 92.1 t -61.65 -34.09 60.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.429 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.32 -51.83 56.37 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.863 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.24 -32.93 73.67 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 8.4 p -58.62 -18.52 31.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.79 -36.83 77.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 109.951 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -25.48 36.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.429 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 37' ' ' SER . 72.1 p -95.48 8.76 42.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.52 151.11 22.28 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.78 147.89 43.02 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 tt -44.87 -46.21 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.644 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.02 -30.03 20.27 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.784 -1.197 . . . . 0.0 114.156 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -87.47 -0.9 57.48 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.391 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.16 -0.68 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 110.44 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.6 tp -84.24 -33.37 24.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.547 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.92 -52.52 60.67 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 58.6 Cg_endo -73.71 -37.53 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.053 1.169 . . . . 0.0 111.123 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -44.12 -52.23 7.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.561 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.07 -35.82 81.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.085 0.469 . . . . 0.0 110.539 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.97 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.872 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 49' ' ' PRO . 35.1 mm -64.42 -44.21 97.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.259 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 58' ' ' THR . 88.6 m-85 -62.1 -33.44 74.44 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.14 -42.36 95.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.78 -42.37 98.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.445 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -70.87 -31.98 68.83 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.69 -0.3 . . . . 0.0 110.549 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 21.0 m -56.62 -58.73 6.81 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.269 -0.973 . . . . 0.0 108.783 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.99 -28.09 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 CA-C-O 121.436 0.636 . . . . 0.0 111.172 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -65.3 -29.19 69.93 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.493 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.44 84.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.351 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.74 -21.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -66.38 -50.38 63.68 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.048 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -49.29 -34.38 15.29 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -77.51 -55.32 5.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.696 0.76 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -60.09 -45.35 93.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.405 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.43 ' C ' ' H ' ' A' ' 69' ' ' ASP . 3.6 pp0? -64.92 -30.47 71.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.104 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.65 43.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 67' ' ' GLN . 91.6 m-20 55.36 81.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 144.77 31.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.452 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 p -76.21 161.65 28.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.8 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.618 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.3 -29.73 67.66 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.033 0.444 . . . . 0.0 110.508 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.85 -47.92 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.466 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.61 65.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.53 -30.48 71.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.037 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 24' ' ' THR . 9.2 t -50.71 -19.83 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.034 0.533 . . . . 0.0 111.004 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.1 p -58.93 -21.23 57.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -87.48 -8.34 56.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.648 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.6 m -60.62 -48.62 92.82 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.736 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 24' ' ' THR . 32.2 Cg_endo -60.71 -40.28 56.28 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 121.512 1.475 . . . . 0.0 111.55 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -75.12 -25.78 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.688 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.1 tp -73.18 -37.52 66.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.887 -0.508 . . . . 0.0 110.584 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.9 -50.08 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.403 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.15 -32.01 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.149 0.499 . . . . 0.0 110.432 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -55.57 -45.06 77.39 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.207 -177.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.55 -38.21 90.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.32 1.057 . . . . 0.0 111.133 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.1 -43.43 88.56 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.771 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.2 t -61.38 -44.32 98.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.89 -34.52 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.07 -51.09 60.42 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.17 -32.53 71.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -59.21 -18.56 37.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.859 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.54 72.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 109.759 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 39' ' ' LEU . 4.3 mm? -49.18 -24.58 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.592 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -95.58 10.99 34.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.125 0.488 . . . . 0.0 110.294 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.23 151.33 21.95 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.41 145.78 43.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.735 -0.274 . . . . 0.0 111.103 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.6 tp -44.36 -42.33 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.945 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 64.5 t0 -88.39 -30.27 19.62 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -88.96 0.4 56.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.677 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.2 p -101.91 -1.09 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.792 1.178 . . . . 0.0 109.931 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.81 -35.17 20.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.23 0.538 . . . . 0.0 111.892 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -52.58 1.19 Allowed Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.21 -34.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.994 2.462 . . . . 0.0 115.176 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.72 -48.82 52.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.312 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 tp -71.28 -27.38 63.38 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.18 63.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 4.0 pt -63.02 -40.95 90.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.978 0.418 . . . . 0.0 110.803 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 76.0 t80 -59.77 -36.27 76.33 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.727 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.17 -42.56 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.715 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.47 -41.5 97.14 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.2 mt -72.66 -32.57 65.93 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.798 -0.236 . . . . 0.0 110.707 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 m -55.28 -57.68 10.82 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.599 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.38 -30.11 48.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 45.0 t80 -62.86 -28.01 69.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.13 91.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.481 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.77 -22.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -66.6 -47.47 72.59 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -54.23 -40.35 67.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 0.0 111.557 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -70.34 -40.31 74.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.821 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -69.4 -44.85 70.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.159 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ALA . 11.7 tp-100 -49.82 -46.15 50.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 17' ' ' LEU . 10.9 mp -71.45 -29.9 65.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.028 0.442 . . . . 0.0 110.91 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -60.33 -48.75 86.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.0 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.82 -24.62 65.31 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.336 0.588 . . . . 0.0 110.602 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.1 tp -62.31 -30.35 71.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.911 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.586 ' O ' ' OG1' ' A' ' 24' ' ' THR . 32.5 t -50.89 -19.52 1.03 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -57.53 -20.54 32.39 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.384 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' A' ' 27' ' ' LEU . 55.7 m-85 -86.14 -10.83 54.08 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.734 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.605 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 p -55.88 -49.08 95.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.394 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -58.37 -43.27 47.74 Favored 'Trans proline' 0 N--CA 1.511 2.501 0 C-N-CA 122.408 2.072 . . . . 0.0 113.012 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.34 -25.34 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.089 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 23' ' ' PHE . 1.2 mm? -73.42 -38.18 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.517 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.82 -51.64 70.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.982 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.97 -42.58 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 33' ' ' VAL . 53.4 tp -53.13 -45.09 68.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.36 -37.25 86.47 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.19 0.995 . . . . 0.0 111.452 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.73 -42.99 69.21 Favored Glycine 0 CA--C 1.543 1.811 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.134 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.9 p -57.75 -33.72 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.13 -39.32 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.04 -51.51 53.37 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 119.192 -1.48 . . . . 0.0 109.542 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.46 -32.13 69.96 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.995 0.426 . . . . 0.0 110.038 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t -57.32 -17.85 14.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.51 -38.84 75.31 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -48.25 -25.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.917 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 m -96.2 9.82 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 110.436 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.87 150.74 21.76 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.09 146.68 43.42 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.262 -0.175 . . . . 0.0 110.77 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.8 tp -43.86 -43.5 6.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.771 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 37.7 p30 -89.02 -29.85 19.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.1 t80 -88.35 0.29 56.34 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.671 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.0 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.7 p -100.02 0.44 10.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-N 119.56 1.073 . . . . 0.0 109.839 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.6 mm? -85.67 -34.93 21.19 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.151 -0.968 . . . . 0.0 112.379 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 -52.19 1.22 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -91.62 -34.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.492 2.128 . . . . 0.0 114.967 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.51 -50.4 38.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.239 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 tp -70.59 -27.26 63.97 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.935 0.397 . . . . 0.0 111.043 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.46 65.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.896 0.379 . . . . 0.0 111.672 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.91 -33.17 71.51 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.47 -42.33 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.61 98.26 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.486 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -32.09 68.52 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.863 -0.198 . . . . 0.0 110.664 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -56.33 -58.35 8.38 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.172 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.02 -27.71 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.078 0.466 . . . . 0.0 110.778 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -66.16 -29.39 69.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.53 83.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.381 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 pt -70.64 -21.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.84 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -66.28 -49.19 67.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -49.31 -31.54 9.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.709 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 tttt -76.33 -54.29 6.97 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.93 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.25 -44.09 95.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.119 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.33 -38.45 63.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.25 -28.8 64.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.294 0.568 . . . . 0.0 110.732 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -60.1 -46.14 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.847 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.74 65.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.478 0.656 . . . . 0.0 110.898 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.54 -29.62 68.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.039 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.0 t -52.21 -21.33 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.685 0.279 . . . . 0.0 111.132 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.2 m -59.27 -20.5 54.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LEU . 72.6 m-85 -89.87 -10.04 46.77 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.567 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.649 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 m -56.66 -48.06 97.88 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 24' ' ' THR . 34.2 Cg_endo -61.96 -37.05 68.24 Favored 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 122.372 2.048 . . . . 0.0 111.938 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.01 -26.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.939 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 23' ' ' PHE . 52.2 tp -77.24 -40.63 44.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.659 0.266 . . . . 0.0 111.517 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.7 p -60.42 -52.33 62.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.792 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.613 ' N ' HG13 ' A' ' 28' ' ' VAL . 10.4 tp -64.09 -39.07 84.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 109.659 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 44.2 tp -52.8 -44.27 66.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.555 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.93 -34.26 77.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.963 0.887 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.48 -42.09 74.61 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.289 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.7 p -56.49 -32.02 35.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.06 -33.23 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -51.24 60.03 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.55 -29.06 58.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 p -55.56 -17.16 4.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.79 77.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.348 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 39' ' ' LEU . 10.7 mp -49.68 -23.8 1.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.786 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 p -94.57 11.17 31.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.299 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.95 154.66 24.76 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 46' ' ' VAL . 1.1 t80 -73.5 147.79 43.73 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.632 -0.334 . . . . 0.0 110.268 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.5 mm? -44.57 -44.25 8.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.44 -0.315 . . . . 0.0 110.416 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 47.0 p-10 -88.94 -30.36 18.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 8.3 t80 -88.69 1.24 55.46 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.312 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 8.3 p -100.26 1.02 10.48 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-N 119.493 1.042 . . . . 0.0 110.701 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.87 -31.88 23.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.635 0.731 . . . . 0.0 112.797 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.29 -51.58 13.26 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.432 -178.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 72.7 Cg_endo -83.84 -26.5 1.97 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 123.565 2.844 . . . . 0.0 113.465 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -68.95 -50.52 48.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.562 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -70.29 -27.66 64.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.052 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.2 -29.31 67.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 111.574 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.2 mm -65.93 -43.65 92.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.174 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -62.24 -32.65 73.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.39 -41.86 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.81 -41.97 97.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.862 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.9 mm? -73.06 -31.37 64.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -56.68 -59.36 5.12 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.583 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.21 -27.47 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.76 -27.1 69.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.742 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.76 97.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.222 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.6 mt -68.35 -21.99 26.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -66.99 -48.01 69.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -49.41 -34.46 16.43 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.898 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 tptm -77.18 -55.7 5.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.885 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -59.94 -44.0 94.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.839 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -55.47 -38.52 69.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.733 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.09 -29.05 64.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.184 0.516 . . . . 0.0 110.941 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -60.25 -47.48 92.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.735 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.82 66.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.573 0.701 . . . . 0.0 110.768 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.69 -28.62 68.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.4 p -51.69 -20.95 2.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.175 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 m -58.35 -19.97 39.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 27' ' ' LEU . 69.9 m-85 -89.59 -10.48 45.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.65 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 6.6 m -55.5 -48.87 95.41 Favored Pre-proline 0 CA--C 1.528 0.125 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -60.98 -36.48 82.61 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.786 2.324 . . . . 0.0 111.558 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -79.13 -25.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.899 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' PHE . 55.5 tp -74.19 -39.56 63.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.019 0.438 . . . . 0.0 112.122 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 29' ' ' ILE . 3.9 m -60.61 -52.05 65.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' H ' HG23 ' A' ' 28' ' ' VAL . 22.4 pt -63.79 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 34' ' ' VAL . 55.9 tp -54.93 -43.93 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.357 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.3 -34.68 78.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.94 0.876 . . . . 0.0 111.067 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.68 94.49 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.91 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 33' ' ' VAL . 2.4 p -65.4 -47.42 86.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' LEU . 27.1 m -70.3 -31.83 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.821 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.53 -52.3 52.66 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.196 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 39' ' ' LEU . 97.9 mt -55.51 -29.13 58.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -54.59 -15.7 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.017 0.823 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.84 -40.37 84.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 111.716 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -44.02 -23.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.983 ' N ' HD13 ' A' ' 39' ' ' LEU . 23.2 m -93.73 11.72 28.11 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.679 0.752 . . . . 0.0 109.48 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.71 152.93 22.8 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.37 146.59 42.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.544 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 43' ' ' LEU . 11.0 mp -43.82 -44.92 7.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.373 -0.204 . . . . 0.0 111.498 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 66.4 t0 -88.74 -31.3 18.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.92 2.69 50.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.188 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.027 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.9 p -101.95 0.78 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.151 0.887 . . . . 0.0 110.384 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.05 -34.68 17.89 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.049 -1.032 . . . . 0.0 112.912 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -79.42 -53.02 1.09 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.007 -177.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 73.8 Cg_endo -90.29 -35.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 122.424 2.083 . . . . 0.0 113.919 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -72.02 -51.93 19.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.249 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.5 -28.02 67.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.892 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 48' ' ' LEU . . . -58.54 -28.05 65.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.402 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.96 -43.76 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.532 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -61.56 -32.21 72.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.627 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -63.62 -41.39 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.53 96.72 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.64 -31.4 65.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -56.68 -60.38 3.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.555 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.85 -27.96 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-O 120.863 0.363 . . . . 0.0 110.527 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.04 -27.14 68.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.164 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.38 97.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.357 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.96 -21.96 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.69 -46.38 75.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 84.8 mtp180 -49.52 -30.16 7.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.193 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.11 -56.74 4.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -58.97 -44.63 91.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.247 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.37 -30.18 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.38 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.09 -30.39 68.69 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.217 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.17 -47.38 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.341 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.08 66.79 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.53 -30.26 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.015 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 24' ' ' THR . 8.2 m -50.31 -20.18 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.859 0.464 . . . . 0.0 110.7 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 6.4 m -57.87 -19.7 31.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -88.09 -10.74 49.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.82 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -58.78 -43.67 98.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.29 -177.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 37.8 Cg_exo -63.15 -43.22 19.65 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.011 2.474 . . . . 0.0 111.212 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.28 -25.65 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.35 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.6 tt -72.58 -38.02 68.0 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.933 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.49 -51.25 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.107 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.57 -35.06 73.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.0 tt -56.44 -44.1 80.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.555 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.9 -36.9 85.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.55 1.166 . . . . 0.0 110.797 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.78 76.84 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.908 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.4 p -58.22 -34.86 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.86 -35.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.302 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.49 -51.79 56.7 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.28 -33.34 74.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.5 m -58.91 -18.8 36.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.741 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.57 79.67 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 109.968 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -25.53 25.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.1 6.98 47.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.147 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.649 ' HA3' HG12 ' A' ' 46' ' ' VAL . . . -90.07 155.21 24.29 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 46' ' ' VAL . 1.1 t80 -74.02 145.81 44.24 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.736 -0.273 . . . . 0.0 111.247 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 tp -43.03 -41.64 3.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.644 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -87.57 -27.43 22.57 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -86.04 1.32 50.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.067 -1.424 . . . . 0.0 113.184 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 42' ' ' TYR . 20.1 m -96.76 1.06 10.52 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.026 0 CA-C-N 119.738 1.154 . . . . 0.0 110.614 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 mt -83.38 -32.56 26.12 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 111.437 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -51.59 -52.12 63.25 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.158 -177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 Cg_endo -76.74 -36.89 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.27 1.313 . . . . 0.0 110.992 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.41 -53.93 8.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.835 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.54 -37.07 82.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.871 -0.518 . . . . 0.0 110.943 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -63.79 -30.96 71.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.441 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.89 -44.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.924 0.392 . . . . 0.0 110.97 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 58' ' ' THR . 59.0 t80 -64.47 -36.78 85.29 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.152 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.97 -42.87 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.99 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.54 -42.58 99.69 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.618 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.868 0.334 . . . . 0.0 110.635 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 54' ' ' PHE . 53.5 m -55.8 -58.83 6.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.449 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.71 -29.17 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.61 -29.17 70.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.16 80.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.193 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.8 mm -68.6 -22.59 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -66.88 -49.52 65.36 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.685 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -54.34 -41.23 68.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.442 0.639 . . . . 0.0 111.333 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.15 -40.36 71.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.624 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -71.07 -45.63 63.41 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.382 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 57.3 tt0 -50.26 -49.94 51.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.405 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.25 52.2 tp -47.29 -35.0 7.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.86 -32.77 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.874 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -74.04 -20.27 60.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.788 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.86 -46.85 88.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.158 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -75.59 -25.86 57.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 110.097 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -61.37 -21.87 64.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.407 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 27' ' ' LEU . 70.8 m-85 -87.38 -8.12 56.96 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.304 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m -61.85 -49.38 86.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.479 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 24' ' ' THR . 27.6 Cg_endo -59.93 -41.6 52.11 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.429 1.419 . . . . 0.0 111.26 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.87 -25.99 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.598 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.1 tt -71.76 -37.34 70.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.292 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.53 -50.18 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.13 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.42 -36.91 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.113 0.483 . . . . 0.0 109.702 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.12 -46.35 65.31 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.67 -37.8 88.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.146 0.974 . . . . 0.0 111.484 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.14 -43.83 93.3 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.921 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.36 -44.39 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.23 -38.19 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.6 -51.7 54.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.65 -34.0 74.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.193 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -58.19 -18.2 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.18 81.66 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.91 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 tp -50.71 -25.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.34 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -95.86 9.87 39.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.54 22.62 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 147.3 44.39 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.686 -0.302 . . . . 0.0 110.614 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 43' ' ' LEU . 58.7 mt -44.86 -44.91 9.93 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.338 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.74 -30.3 19.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -88.0 -0.68 57.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.298 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.3 2.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 119.301 0.955 . . . . 0.0 110.204 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -82.87 -32.69 27.28 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 110.607 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.2 mp -51.72 -52.89 56.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.922 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.5 Cg_endo -73.88 -36.02 3.9 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.052 1.168 . . . . 0.0 111.583 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.13 -53.53 10.23 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.158 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -66.16 -35.38 80.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.19 0.45 . . . . 0.0 110.297 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.9 -29.4 70.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.454 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.97 -43.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.48 -34.43 77.74 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.36 -42.31 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.5 97.99 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.442 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -73.43 -32.03 64.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.5 m -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.743 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.5 -29.48 46.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.19 -27.42 68.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.23 0.538 . . . . 0.0 112.235 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.63 -44.12 97.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.497 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.6 -22.35 25.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.454 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -67.04 -47.56 71.0 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.369 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -50.76 -37.66 43.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.326 0.584 . . . . 0.0 110.958 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -71.46 -43.98 65.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.768 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -70.36 -46.62 63.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.215 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.7 -29.98 70.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.741 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.785 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -54.39 -43.67 71.61 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.616 0.644 . . . . 0.0 111.823 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.79 -32.5 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.14 -42.71 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.776 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -74.27 -26.24 60.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.342 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.5 p -61.38 -22.73 65.23 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 27' ' ' LEU . 84.2 m-85 -87.42 -9.38 54.84 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.671 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.573 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 3.1 m -58.67 -49.0 95.82 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.919 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.0 Cg_endo -61.17 -36.42 80.86 Favored 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.257 1.971 . . . . 0.0 112.402 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.03 -26.38 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.79 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.0 tt -80.07 -40.22 28.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.83 0.287 . . . . 0.0 111.526 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.2 p -58.93 -52.01 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.7 tt -61.84 -32.46 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.21 0.529 . . . . 0.0 110.044 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -58.13 -43.29 87.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.061 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.7 -38.15 90.01 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.382 1.087 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.01 -44.52 98.1 Favored Glycine 0 CA--C 1.549 2.209 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.664 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 33' ' ' VAL . 5.7 m -66.61 -47.04 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.093 0.446 . . . . 0.0 110.946 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 30' ' ' LEU . 31.6 m -70.79 -32.05 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.661 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.83 -52.04 55.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.41 -34.44 77.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.974 0.416 . . . . 0.0 110.157 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 40' ' ' THR . 16.5 p -59.86 -19.37 50.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.614 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.6 -36.51 71.84 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.039 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.7 tp -45.48 -23.01 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -93.62 11.98 26.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.547 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.93 152.0 22.62 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.71 147.18 45.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -44.31 -45.03 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.285 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 65.8 t0 -89.61 -30.61 18.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 122.553 1.168 . . . . 0.0 114.146 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -86.62 -0.88 57.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.477 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.38 1.61 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 119.106 0.866 . . . . 0.0 110.129 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.8 mp -83.12 -32.79 26.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.86 -52.26 62.95 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 61.3 Cg_endo -74.67 -35.55 3.43 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.18 1.253 . . . . 0.0 111.105 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.45 10.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.884 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -66.72 -36.71 83.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.635 0.255 . . . . 0.0 110.601 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -58.26 -27.25 63.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.049 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.32 -42.96 97.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -60.39 -32.72 71.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.882 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.7 mp -64.96 -42.08 93.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.4 -42.73 97.63 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.4 mt -70.86 -32.49 69.51 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.717 -0.284 . . . . 0.0 110.772 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 m -56.41 -57.97 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.752 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 62' ' ' ILE . 77.9 mt -61.55 -29.02 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 120.928 0.394 . . . . 0.0 111.156 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 24' ' ' THR . 40.7 t80 -63.98 -28.42 69.8 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.68 77.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.954 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 59' ' ' ILE . 14.2 tt -68.14 -23.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.346 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.11 -49.41 67.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.343 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -49.39 -32.04 10.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.922 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.42 -54.79 6.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.822 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -61.99 -45.11 95.06 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.553 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 94.6 mt-30 -65.91 -30.24 70.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.136 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.779 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -47.81 -38.26 15.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.27 -32.87 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.93 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.99 61.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.84 -45.23 95.33 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.595 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.2 p -72.29 -26.01 61.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.99 0.424 . . . . 0.0 110.609 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.2 -22.62 64.92 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.945 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -89.76 -9.06 50.73 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.255 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 16.8 m -58.59 -48.3 97.15 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 24' ' ' THR . 33.4 Cg_endo -61.35 -37.96 68.46 Favored 'Trans proline' 0 N--CA 1.513 2.634 0 C-N-CA 122.314 2.009 . . . . 0.0 112.54 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.45 -26.33 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.865 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.9 tt -79.17 -40.54 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.91 0.323 . . . . 0.0 111.657 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.6 p -58.92 -52.12 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.56 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.1 tt -61.21 -32.66 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.512 . . . . 0.0 110.094 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.573 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.71 -44.34 85.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.572 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.34 -38.87 92.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.269 1.033 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.64 -43.65 86.21 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.782 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.21 -44.42 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.6 -35.55 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.592 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.7 -51.8 56.84 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.67 -32.83 73.03 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -18.51 28.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.04 79.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.13 0.491 . . . . 0.0 109.998 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 39' ' ' LEU . 4.2 mm? -52.42 -25.14 9.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.132 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -95.84 8.89 42.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.074 0.464 . . . . 0.0 110.155 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.79 152.02 22.76 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -73.48 146.48 44.9 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -44.62 -45.24 9.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.503 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.84 -30.61 18.82 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -86.79 -0.7 56.87 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.46 2.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 119.079 0.854 . . . . 0.0 109.77 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -83.02 -32.55 26.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 111.278 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -51.23 -52.6 57.43 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.162 -177.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 59.4 Cg_endo -73.65 -35.5 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.056 1.17 . . . . 0.0 110.927 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.75 -53.71 9.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.966 -174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -67.13 -35.81 80.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.113 0.483 . . . . 0.0 110.617 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.39 -28.85 70.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.297 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.95 -43.74 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.543 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.868 ' O ' HG23 ' A' ' 58' ' ' THR . 92.3 m-85 -61.84 -32.68 73.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.361 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.83 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.441 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.87 -42.89 99.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.989 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 57' ' ' LEU . 10.7 mp -72.92 -35.64 67.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.921 0.361 . . . . 0.0 111.566 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.868 HG23 ' O ' ' A' ' 54' ' ' PHE . 29.9 p -54.41 -59.72 4.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.909 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.99 -29.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.76 -27.55 69.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.197 0.522 . . . . 0.0 112.184 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.59 98.57 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.608 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.25 -22.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.8 -47.88 70.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.426 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -51.27 -36.94 44.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.167 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.3 -54.54 6.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.625 0.726 . . . . 0.0 110.967 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.14 -45.0 96.46 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.559 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.39 -30.67 71.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.779 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.468 179.781 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.559 0.219 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' CD2' ' H ' ' A' ' 17' ' ' LEU 0.255 4.2 mm? -49.11 -40.17 31.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.956 0.502 . . . . 0.0 111.769 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.31 -32.5 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.843 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.14 61.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.621 0.248 . . . . 0.0 111.661 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.04 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.923 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.0 p -70.09 -26.31 63.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.973 0.416 . . . . 0.0 110.928 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 p -60.9 -22.59 64.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.624 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' LEU . 98.0 m-85 -87.94 -9.67 52.87 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.248 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 m -57.79 -48.26 97.48 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.372 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.4 Cg_endo -60.37 -40.73 55.64 Favored 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.444 2.096 . . . . 0.0 112.75 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.92 -27.13 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' PHE . 57.2 tp -76.54 -40.44 49.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 29' ' ' ILE . 9.1 p -59.41 -50.72 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.569 ' N ' HG13 ' A' ' 28' ' ' VAL . 64.5 mt -60.53 -35.84 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 30' ' ' LEU . 5.1 tt -53.43 -44.94 69.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.262 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.87 -38.95 92.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.121 0.962 . . . . 0.0 111.3 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.8 70.76 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.411 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.74 -43.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.68 -42.04 94.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.942 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.72 -52.36 46.37 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 36' ' ' LEU . 11.1 mp -62.84 -33.93 76.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 p -59.93 -18.9 48.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.72 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.943 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -50.81 -25.75 4.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.24 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.0 p -96.33 8.98 42.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 150.99 22.09 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.15 148.16 41.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.669 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 tp -43.8 -45.67 7.42 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.176 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.16 -29.69 20.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.2 -0.26 56.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.792 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.45 0.14 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 CA-C-N 119.366 0.984 . . . . 0.0 110.382 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.41 -32.38 24.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.228 0.537 . . . . 0.0 111.503 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -51.57 -52.08 63.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.172 -178.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 Cg_endo -75.64 -36.39 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.061 1.174 . . . . 0.0 110.932 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.6 7.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.579 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.05 -36.45 82.06 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.461 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -62.96 -28.34 70.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.316 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.34 -44.65 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.349 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.43 -34.86 78.89 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 52' ' ' ALA . 15.9 tt -65.76 -37.34 79.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.24 98.28 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.99 -31.88 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.559 0.218 . . . . 0.0 110.543 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 m -57.18 -57.87 10.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.792 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.008 0.432 . . . . 0.0 111.405 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 49.7 t80 -61.96 -27.34 68.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.13 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.42 99.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.615 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.28 -22.0 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -65.94 -46.94 76.36 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -49.85 -35.1 21.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.26 -37.72 66.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.538 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -72.15 -43.73 64.19 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 87.9 mt-30 -50.54 -44.14 56.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.255 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.141 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 17' ' ' LEU . 65.9 p . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 16' ' ' THR . 47.0 tp -56.26 -43.29 78.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.531 0.605 . . . . 0.0 111.955 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.03 -33.8 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 0.0 111.131 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -71.19 -19.14 62.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.535 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.09 -46.06 90.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.715 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.4 t -75.35 -26.08 58.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 110.881 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 57.7 p -61.1 -21.87 64.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.772 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 27' ' ' LEU . 55.8 m-85 -89.54 -9.08 51.22 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.195 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.594 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -58.19 -48.23 97.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.262 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 24' ' ' THR . 37.2 Cg_endo -62.5 -34.95 74.14 Favored 'Trans proline' 0 N--CA 1.51 2.459 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -85.29 -26.13 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.308 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.5 tp -77.71 -40.35 41.54 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.137 -0.352 . . . . 0.0 111.35 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.9 p -60.03 -52.2 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.495 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.9 pt -62.78 -37.74 79.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.88 -44.35 74.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.826 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.23 -37.68 88.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.061 0.934 . . . . 0.0 111.274 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.29 -43.75 75.41 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.709 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.22 -43.79 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.65 -34.09 60.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.429 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.32 -51.83 56.37 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.863 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 36' ' ' LEU . 11.2 mp -62.24 -32.93 73.67 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' OG1' ' A' ' 40' ' ' THR . 8.4 p -58.62 -18.52 31.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.79 -36.83 77.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 109.951 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -55.46 -25.48 36.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.429 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 37' ' ' SER . 72.1 p -95.48 8.76 42.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.52 151.11 22.28 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.78 147.89 43.02 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 43' ' ' LEU . 2.1 tt -44.87 -46.21 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.644 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.02 -30.03 20.27 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.784 -1.197 . . . . 0.0 114.156 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -87.47 -0.9 57.48 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.391 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.16 -0.68 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 110.44 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.6 tp -84.24 -33.37 24.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.547 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.92 -52.52 60.67 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 58.6 Cg_endo -73.71 -37.53 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.053 1.169 . . . . 0.0 111.123 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -44.12 -52.23 7.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.561 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.07 -35.82 81.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.085 0.469 . . . . 0.0 110.539 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 49' ' ' PRO . . . -59.91 -27.97 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.872 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 49' ' ' PRO . 35.1 mm -64.42 -44.21 97.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.259 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 58' ' ' THR . 88.6 m-85 -62.1 -33.44 74.44 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.14 -42.36 95.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.78 -42.37 98.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.445 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -70.87 -31.98 68.83 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.69 -0.3 . . . . 0.0 110.549 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 21.0 m -56.62 -58.73 6.81 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.269 -0.973 . . . . 0.0 108.783 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.99 -28.09 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 CA-C-O 121.436 0.636 . . . . 0.0 111.172 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -65.3 -29.19 69.93 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.493 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.44 84.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.351 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.74 -21.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -66.38 -50.38 63.68 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.048 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 72.7 ttt180 -49.29 -34.38 15.29 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -77.51 -55.32 5.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.696 0.76 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -60.09 -45.35 93.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.405 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -30.47 71.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.104 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mm . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.882 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -54.55 -32.75 53.55 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.78 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.6 m -59.59 -47.06 87.05 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 m -57.16 -48.83 77.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.976 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.3 -29.73 67.66 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.033 0.444 . . . . 0.0 110.508 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 14' ' ' GLY . 42.8 t -60.85 -47.92 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.466 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.61 65.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.53 -30.48 71.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.037 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 24' ' ' THR . 9.2 t -50.71 -19.83 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.034 0.533 . . . . 0.0 111.004 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.1 p -58.93 -21.23 57.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -87.48 -8.34 56.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.648 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.6 m -60.62 -48.62 92.82 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.736 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 24' ' ' THR . 32.2 Cg_endo -60.71 -40.28 56.28 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 121.512 1.475 . . . . 0.0 111.55 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -75.12 -25.78 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.688 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.1 tp -73.18 -37.52 66.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.887 -0.508 . . . . 0.0 110.584 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.9 -50.08 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.403 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.15 -32.01 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.149 0.499 . . . . 0.0 110.432 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -55.57 -45.06 77.39 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.207 -177.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.55 -38.21 90.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.32 1.057 . . . . 0.0 111.133 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.1 -43.43 88.56 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.771 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.2 t -61.38 -44.32 98.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.89 -34.52 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.07 -51.09 60.42 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.17 -32.53 71.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -59.21 -18.56 37.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.859 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.54 72.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 109.759 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 39' ' ' LEU . 4.3 mm? -49.18 -24.58 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.592 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -95.58 10.99 34.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.125 0.488 . . . . 0.0 110.294 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.23 151.33 21.95 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.41 145.78 43.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.735 -0.274 . . . . 0.0 111.103 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.6 tp -44.36 -42.33 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.945 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 64.5 t0 -88.39 -30.27 19.62 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -88.96 0.4 56.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.677 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.2 p -101.91 -1.09 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.792 1.178 . . . . 0.0 109.931 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.81 -35.17 20.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.23 0.538 . . . . 0.0 111.892 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -52.58 1.19 Allowed Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.21 -34.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.994 2.462 . . . . 0.0 115.176 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.72 -48.82 52.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.312 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 tp -71.28 -27.38 63.38 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.18 63.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 4.0 pt -63.02 -40.95 90.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.978 0.418 . . . . 0.0 110.803 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 76.0 t80 -59.77 -36.27 76.33 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.727 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.17 -42.56 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.715 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.47 -41.5 97.14 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.2 mt -72.66 -32.57 65.93 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.798 -0.236 . . . . 0.0 110.707 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 m -55.28 -57.68 10.82 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.599 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.38 -30.11 48.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 45.0 t80 -62.86 -28.01 69.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.13 91.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.481 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.77 -22.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -66.6 -47.47 72.59 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -54.23 -40.35 67.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 0.0 111.557 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -70.34 -40.31 74.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.821 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -69.4 -44.85 70.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.159 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ALA . 11.7 tp-100 -49.82 -46.15 50.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' ALA . . . 31.37 65.62 0.17 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 98.4 m-20 54.43 -80.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 69' ' ' ASP . . . 79.4 -148.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.5 m -60.09 -41.83 93.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.593 -179.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.562 HG23 ' N ' ' A' ' 14' ' ' GLY . 20.8 tt . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.887 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.99 -34.22 51.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.296 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 p -59.7 -48.9 79.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.267 1.033 . . . . 0.0 108.371 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 25.9 p -54.93 -47.3 74.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.528 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 17' ' ' LEU . 10.9 mp -71.45 -29.9 65.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.028 0.442 . . . . 0.0 110.91 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 14' ' ' GLY . 26.3 t -60.33 -48.75 86.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.0 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.82 -24.62 65.31 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.336 0.588 . . . . 0.0 110.602 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.1 tp -62.31 -30.35 71.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.911 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.586 ' O ' ' OG1' ' A' ' 24' ' ' THR . 32.5 t -50.89 -19.52 1.03 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -57.53 -20.54 32.39 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.384 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' A' ' 27' ' ' LEU . 55.7 m-85 -86.14 -10.83 54.08 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.734 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.605 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 p -55.88 -49.08 95.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.394 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -58.37 -43.27 47.74 Favored 'Trans proline' 0 N--CA 1.511 2.501 0 C-N-CA 122.408 2.072 . . . . 0.0 113.012 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.34 -25.34 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.089 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 23' ' ' PHE . 1.2 mm? -73.42 -38.18 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.517 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.82 -51.64 70.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.982 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.97 -42.58 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 33' ' ' VAL . 53.4 tp -53.13 -45.09 68.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.36 -37.25 86.47 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.19 0.995 . . . . 0.0 111.452 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.73 -42.99 69.21 Favored Glycine 0 CA--C 1.543 1.811 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.134 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.9 p -57.75 -33.72 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.13 -39.32 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.04 -51.51 53.37 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 119.192 -1.48 . . . . 0.0 109.542 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.46 -32.13 69.96 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.995 0.426 . . . . 0.0 110.038 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t -57.32 -17.85 14.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.51 -38.84 75.31 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -48.25 -25.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.917 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 m -96.2 9.82 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 110.436 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.87 150.74 21.76 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.09 146.68 43.42 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.262 -0.175 . . . . 0.0 110.77 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.8 tp -43.86 -43.5 6.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.771 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 37.7 p30 -89.02 -29.85 19.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.1 t80 -88.35 0.29 56.34 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.671 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.0 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.7 p -100.02 0.44 10.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-N 119.56 1.073 . . . . 0.0 109.839 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.6 mm? -85.67 -34.93 21.19 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.151 -0.968 . . . . 0.0 112.379 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 -52.19 1.22 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -91.62 -34.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.492 2.128 . . . . 0.0 114.967 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.51 -50.4 38.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.239 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 tp -70.59 -27.26 63.97 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.935 0.397 . . . . 0.0 111.043 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.46 65.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.896 0.379 . . . . 0.0 111.672 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.91 -33.17 71.51 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.47 -42.33 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.61 98.26 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.486 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -32.09 68.52 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.863 -0.198 . . . . 0.0 110.664 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -56.33 -58.35 8.38 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.172 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.02 -27.71 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.078 0.466 . . . . 0.0 110.778 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -66.16 -29.39 69.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.53 83.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.381 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 pt -70.64 -21.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.84 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -66.28 -49.19 67.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -49.31 -31.54 9.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.709 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 tttt -76.33 -54.29 6.97 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.93 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.25 -44.09 95.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.119 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.33 -38.45 63.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . -51.37 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.544 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -71.16 -42.48 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 53.19 92.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.352 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.1 m -70.22 148.97 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.595 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.579 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.908 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.89 -37.57 58.09 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.0 p -59.18 -48.98 79.62 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.313 1.054 . . . . 0.0 108.95 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.2 p -55.73 -48.02 75.91 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.754 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.25 -28.8 64.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.294 0.568 . . . . 0.0 110.732 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 14' ' ' GLY . 20.0 t -60.1 -46.14 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.847 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.74 65.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.478 0.656 . . . . 0.0 110.898 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.54 -29.62 68.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.039 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.0 t -52.21 -21.33 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.685 0.279 . . . . 0.0 111.132 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.2 m -59.27 -20.5 54.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LEU . 72.6 m-85 -89.87 -10.04 46.77 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.567 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.649 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 m -56.66 -48.06 97.88 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 24' ' ' THR . 34.2 Cg_endo -61.96 -37.05 68.24 Favored 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 122.372 2.048 . . . . 0.0 111.938 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.01 -26.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.939 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 23' ' ' PHE . 52.2 tp -77.24 -40.63 44.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.659 0.266 . . . . 0.0 111.517 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.7 p -60.42 -52.33 62.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.792 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.613 ' N ' HG13 ' A' ' 28' ' ' VAL . 10.4 tp -64.09 -39.07 84.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 109.659 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 44.2 tp -52.8 -44.27 66.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.555 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.93 -34.26 77.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.963 0.887 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.48 -42.09 74.61 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.289 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.7 p -56.49 -32.02 35.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.06 -33.23 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -51.24 60.03 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.55 -29.06 58.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 p -55.56 -17.16 4.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.79 77.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.348 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 39' ' ' LEU . 10.7 mp -49.68 -23.8 1.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.786 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 p -94.57 11.17 31.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.299 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.95 154.66 24.76 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 46' ' ' VAL . 1.1 t80 -73.5 147.79 43.73 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.632 -0.334 . . . . 0.0 110.268 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.5 mm? -44.57 -44.25 8.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.44 -0.315 . . . . 0.0 110.416 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 47.0 p-10 -88.94 -30.36 18.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 8.3 t80 -88.69 1.24 55.46 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.312 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 8.3 p -100.26 1.02 10.48 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-N 119.493 1.042 . . . . 0.0 110.701 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.87 -31.88 23.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.635 0.731 . . . . 0.0 112.797 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.29 -51.58 13.26 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.432 -178.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 72.7 Cg_endo -83.84 -26.5 1.97 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 123.565 2.844 . . . . 0.0 113.465 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -68.95 -50.52 48.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.562 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -70.29 -27.66 64.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.052 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.2 -29.31 67.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 111.574 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.2 mm -65.93 -43.65 92.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.174 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -62.24 -32.65 73.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.39 -41.86 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.81 -41.97 97.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.862 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.9 mm? -73.06 -31.37 64.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -56.68 -59.36 5.12 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.583 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.21 -27.47 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.76 -27.1 69.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.742 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.76 97.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.222 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.6 mt -68.35 -21.99 26.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -66.99 -48.01 69.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -49.41 -34.46 16.43 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.898 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 tptm -77.18 -55.7 5.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.885 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -59.94 -44.0 94.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.839 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -55.47 -38.52 69.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.733 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . -52.11 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.818 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -177.04 67.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.603 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -47.88 148.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 0.0 110.55 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -70.34 144.36 51.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.577 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.903 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.01 -37.63 54.2 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -59.32 -47.1 86.69 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.058 0.933 . . . . 0.0 109.347 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -56.81 -48.38 78.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.948 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.09 -29.05 64.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.184 0.516 . . . . 0.0 110.941 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 14' ' ' GLY . 23.1 t -60.25 -47.48 92.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.735 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.82 66.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.573 0.701 . . . . 0.0 110.768 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.69 -28.62 68.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.4 p -51.69 -20.95 2.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.175 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 m -58.35 -19.97 39.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 27' ' ' LEU . 69.9 m-85 -89.59 -10.48 45.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.65 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 6.6 m -55.5 -48.87 95.41 Favored Pre-proline 0 CA--C 1.528 0.125 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -60.98 -36.48 82.61 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.786 2.324 . . . . 0.0 111.558 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -79.13 -25.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.899 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' PHE . 55.5 tp -74.19 -39.56 63.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.019 0.438 . . . . 0.0 112.122 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 29' ' ' ILE . 3.9 m -60.61 -52.05 65.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' H ' HG23 ' A' ' 28' ' ' VAL . 22.4 pt -63.79 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 34' ' ' VAL . 55.9 tp -54.93 -43.93 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.357 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.3 -34.68 78.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.94 0.876 . . . . 0.0 111.067 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.68 94.49 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.91 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 33' ' ' VAL . 2.4 p -65.4 -47.42 86.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' LEU . 27.1 m -70.3 -31.83 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.821 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.53 -52.3 52.66 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.196 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 39' ' ' LEU . 97.9 mt -55.51 -29.13 58.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -54.59 -15.7 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.017 0.823 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.84 -40.37 84.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 111.716 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -44.02 -23.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.983 ' N ' HD13 ' A' ' 39' ' ' LEU . 23.2 m -93.73 11.72 28.11 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.679 0.752 . . . . 0.0 109.48 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.71 152.93 22.8 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.37 146.59 42.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.544 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 43' ' ' LEU . 11.0 mp -43.82 -44.92 7.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.373 -0.204 . . . . 0.0 111.498 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 66.4 t0 -88.74 -31.3 18.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.92 2.69 50.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.188 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.027 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.9 p -101.95 0.78 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.151 0.887 . . . . 0.0 110.384 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.05 -34.68 17.89 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.049 -1.032 . . . . 0.0 112.912 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -79.42 -53.02 1.09 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.007 -177.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 73.8 Cg_endo -90.29 -35.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 122.424 2.083 . . . . 0.0 113.919 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -72.02 -51.93 19.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.249 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.5 -28.02 67.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.892 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 48' ' ' LEU . . . -58.54 -28.05 65.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.402 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.96 -43.76 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.532 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -61.56 -32.21 72.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.627 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -63.62 -41.39 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.53 96.72 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.64 -31.4 65.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -56.68 -60.38 3.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.555 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.85 -27.96 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-O 120.863 0.363 . . . . 0.0 110.527 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.04 -27.14 68.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.164 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.38 97.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.357 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.96 -21.96 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.69 -46.38 75.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 84.8 mtp180 -49.52 -30.16 7.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.193 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.11 -56.74 4.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 79.1 mtp85 -58.97 -44.63 91.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.247 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.37 -30.18 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.38 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -80.4 39.64 0.47 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.813 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 66' ' ' ARG . 5.4 p30 -171.52 -176.64 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.242 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' SER . . . 63.62 -81.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.695 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 p 43.05 18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ALA . 13.9 t . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.555 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.851 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.86 -35.18 52.65 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.9 m -60.28 -47.78 84.53 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -56.6 -48.59 77.09 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.245 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.09 -30.39 68.69 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.217 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 14' ' ' GLY . 27.2 t -60.17 -47.38 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.341 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.08 66.79 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.53 -30.26 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.015 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 24' ' ' THR . 8.2 m -50.31 -20.18 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.859 0.464 . . . . 0.0 110.7 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 6.4 m -57.87 -19.7 31.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -88.09 -10.74 49.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.82 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -58.78 -43.67 98.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.29 -177.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 37.8 Cg_exo -63.15 -43.22 19.65 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.011 2.474 . . . . 0.0 111.212 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.28 -25.65 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.35 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.6 tt -72.58 -38.02 68.0 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.933 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.49 -51.25 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.107 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.57 -35.06 73.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.0 tt -56.44 -44.1 80.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.555 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.9 -36.9 85.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.55 1.166 . . . . 0.0 110.797 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.78 76.84 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.908 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.4 p -58.22 -34.86 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.86 -35.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.302 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.49 -51.79 56.7 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.28 -33.34 74.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.5 m -58.91 -18.8 36.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.741 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.57 79.67 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 109.968 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -25.53 25.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.1 6.98 47.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.147 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.649 ' HA3' HG12 ' A' ' 46' ' ' VAL . . . -90.07 155.21 24.29 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 46' ' ' VAL . 1.1 t80 -74.02 145.81 44.24 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.736 -0.273 . . . . 0.0 111.247 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 tp -43.03 -41.64 3.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.644 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -87.57 -27.43 22.57 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -86.04 1.32 50.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.067 -1.424 . . . . 0.0 113.184 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 42' ' ' TYR . 20.1 m -96.76 1.06 10.52 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.026 0 CA-C-N 119.738 1.154 . . . . 0.0 110.614 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 mt -83.38 -32.56 26.12 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 111.437 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -51.59 -52.12 63.25 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.158 -177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 Cg_endo -76.74 -36.89 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.27 1.313 . . . . 0.0 110.992 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.41 -53.93 8.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.835 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.54 -37.07 82.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.871 -0.518 . . . . 0.0 110.943 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -63.79 -30.96 71.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.441 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.89 -44.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.924 0.392 . . . . 0.0 110.97 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 58' ' ' THR . 59.0 t80 -64.47 -36.78 85.29 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.152 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.97 -42.87 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.99 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.54 -42.58 99.69 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.618 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.868 0.334 . . . . 0.0 110.635 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 54' ' ' PHE . 53.5 m -55.8 -58.83 6.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.449 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.71 -29.17 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.61 -29.17 70.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.16 80.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.193 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.8 mm -68.6 -22.59 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -66.88 -49.52 65.36 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.685 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -54.34 -41.23 68.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.442 0.639 . . . . 0.0 111.333 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.15 -40.36 71.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.624 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -71.07 -45.63 63.41 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.382 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 57.3 tt0 -50.26 -49.94 51.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . 64.91 -40.92 0.29 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.405 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' GLN . 2.0 m-20 176.6 -68.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.15 121.89 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.9 t -62.28 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.686 -179.91 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.88 -42.96 5.54 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-O 122.14 0.856 . . . . 0.0 113.519 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' VAL . 70.6 p -59.46 -48.75 80.44 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.79 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -50.39 8.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.632 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.25 52.2 tp -47.29 -35.0 7.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 15' ' ' THR . 7.9 p -62.86 -32.77 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.874 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -74.04 -20.27 60.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.788 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.86 -46.85 88.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.158 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -75.59 -25.86 57.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 110.097 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -61.37 -21.87 64.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.407 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 27' ' ' LEU . 70.8 m-85 -87.38 -8.12 56.96 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.304 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m -61.85 -49.38 86.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.479 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 24' ' ' THR . 27.6 Cg_endo -59.93 -41.6 52.11 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.429 1.419 . . . . 0.0 111.26 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.87 -25.99 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.598 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.1 tt -71.76 -37.34 70.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.292 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.53 -50.18 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.13 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.42 -36.91 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.113 0.483 . . . . 0.0 109.702 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.12 -46.35 65.31 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.67 -37.8 88.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.146 0.974 . . . . 0.0 111.484 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.14 -43.83 93.3 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.921 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.36 -44.39 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.23 -38.19 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.6 -51.7 54.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.65 -34.0 74.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.193 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -58.19 -18.2 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.18 81.66 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.91 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 tp -50.71 -25.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.34 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -95.86 9.87 39.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.54 22.62 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 147.3 44.39 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.686 -0.302 . . . . 0.0 110.614 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 43' ' ' LEU . 58.7 mt -44.86 -44.91 9.93 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.338 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.74 -30.3 19.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -88.0 -0.68 57.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.298 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.3 2.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 119.301 0.955 . . . . 0.0 110.204 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -82.87 -32.69 27.28 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 110.607 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.2 mp -51.72 -52.89 56.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.922 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.5 Cg_endo -73.88 -36.02 3.9 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.052 1.168 . . . . 0.0 111.583 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.13 -53.53 10.23 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.158 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -66.16 -35.38 80.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.19 0.45 . . . . 0.0 110.297 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.9 -29.4 70.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.454 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.97 -43.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.48 -34.43 77.74 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.36 -42.31 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.5 97.99 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.442 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -73.43 -32.03 64.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.5 m -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.743 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.5 -29.48 46.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.19 -27.42 68.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.23 0.538 . . . . 0.0 112.235 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.63 -44.12 97.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.497 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.6 -22.35 25.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.454 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -67.04 -47.56 71.0 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.369 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -50.76 -37.66 43.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.326 0.584 . . . . 0.0 110.958 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -71.46 -43.98 65.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.768 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -70.36 -46.62 63.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.215 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.7 -29.98 70.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.741 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.65 46.37 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.785 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 67.9 t0 -79.61 -109.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.518 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 69' ' ' ASP . . . 67.29 -57.91 0.42 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.88 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 69' ' ' ASP . 46.3 t -149.33 148.55 29.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.455 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.642 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 14' ' ' GLY . 20.3 tt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -84.48 -41.03 8.04 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.97 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 19' ' ' ALA . 96.2 m -60.5 -48.0 83.69 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.433 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 p -59.7 -61.75 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 117.713 -1.595 . . . . 0.0 111.977 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -54.39 -43.67 71.61 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.616 0.644 . . . . 0.0 111.823 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 14' ' ' GLY . 95.7 t -69.79 -32.5 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 15' ' ' THR . . . -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.14 -42.71 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.776 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -74.27 -26.24 60.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.342 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.5 p -61.38 -22.73 65.23 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 27' ' ' LEU . 84.2 m-85 -87.42 -9.38 54.84 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.671 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.573 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 3.1 m -58.67 -49.0 95.82 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.919 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.0 Cg_endo -61.17 -36.42 80.86 Favored 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.257 1.971 . . . . 0.0 112.402 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.03 -26.38 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.79 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.0 tt -80.07 -40.22 28.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.83 0.287 . . . . 0.0 111.526 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.2 p -58.93 -52.01 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.7 tt -61.84 -32.46 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.21 0.529 . . . . 0.0 110.044 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -58.13 -43.29 87.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.061 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.7 -38.15 90.01 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.382 1.087 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.01 -44.52 98.1 Favored Glycine 0 CA--C 1.549 2.209 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.664 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 33' ' ' VAL . 5.7 m -66.61 -47.04 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.093 0.446 . . . . 0.0 110.946 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 30' ' ' LEU . 31.6 m -70.79 -32.05 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.661 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.83 -52.04 55.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.41 -34.44 77.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.974 0.416 . . . . 0.0 110.157 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 40' ' ' THR . 16.5 p -59.86 -19.37 50.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.614 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.6 -36.51 71.84 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.039 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.7 tp -45.48 -23.01 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -93.62 11.98 26.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.547 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.93 152.0 22.62 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.71 147.18 45.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -44.31 -45.03 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.285 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 65.8 t0 -89.61 -30.61 18.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 122.553 1.168 . . . . 0.0 114.146 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -86.62 -0.88 57.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.477 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.38 1.61 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 119.106 0.866 . . . . 0.0 110.129 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.8 mp -83.12 -32.79 26.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.86 -52.26 62.95 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 61.3 Cg_endo -74.67 -35.55 3.43 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.18 1.253 . . . . 0.0 111.105 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.45 10.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.884 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -66.72 -36.71 83.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.635 0.255 . . . . 0.0 110.601 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -58.26 -27.25 63.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.049 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.32 -42.96 97.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -60.39 -32.72 71.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.882 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.7 mp -64.96 -42.08 93.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.4 -42.73 97.63 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.4 mt -70.86 -32.49 69.51 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.717 -0.284 . . . . 0.0 110.772 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 m -56.41 -57.97 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.752 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 62' ' ' ILE . 77.9 mt -61.55 -29.02 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 120.928 0.394 . . . . 0.0 111.156 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 24' ' ' THR . 40.7 t80 -63.98 -28.42 69.8 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.68 77.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.954 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 59' ' ' ILE . 14.2 tt -68.14 -23.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.346 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.11 -49.41 67.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.343 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -49.39 -32.04 10.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.922 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.42 -54.79 6.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.822 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -61.99 -45.11 95.06 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.553 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 94.6 mt-30 -65.91 -30.24 70.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.136 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . 35.1 86.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.779 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -62.65 -41.32 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.67 33.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.536 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -65.78 145.17 56.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.688 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.494 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -90.28 -42.22 5.29 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 m -60.78 -50.03 75.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.888 -1.156 . . . . 0.0 112.721 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -78.37 -50.29 12.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.789 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -47.81 -38.26 15.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 14' ' ' GLY . 53.9 t -66.27 -32.87 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.93 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.99 61.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.84 -45.23 95.33 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.595 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.2 p -72.29 -26.01 61.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.99 0.424 . . . . 0.0 110.609 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.2 -22.62 64.92 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.945 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -89.76 -9.06 50.73 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.255 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 16.8 m -58.59 -48.3 97.15 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 24' ' ' THR . 33.4 Cg_endo -61.35 -37.96 68.46 Favored 'Trans proline' 0 N--CA 1.513 2.634 0 C-N-CA 122.314 2.009 . . . . 0.0 112.54 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.45 -26.33 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.865 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.9 tt -79.17 -40.54 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.91 0.323 . . . . 0.0 111.657 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.6 p -58.92 -52.12 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.56 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.1 tt -61.21 -32.66 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.512 . . . . 0.0 110.094 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.573 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.71 -44.34 85.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.572 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.34 -38.87 92.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.269 1.033 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.64 -43.65 86.21 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.782 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.21 -44.42 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.6 -35.55 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.592 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.7 -51.8 56.84 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.67 -32.83 73.03 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -18.51 28.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.04 79.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.13 0.491 . . . . 0.0 109.998 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 39' ' ' LEU . 4.2 mm? -52.42 -25.14 9.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.132 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -95.84 8.89 42.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.074 0.464 . . . . 0.0 110.155 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.79 152.02 22.76 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -73.48 146.48 44.9 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -44.62 -45.24 9.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.503 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.84 -30.61 18.82 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -86.79 -0.7 56.87 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.46 2.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 119.079 0.854 . . . . 0.0 109.77 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -83.02 -32.55 26.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 111.278 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -51.23 -52.6 57.43 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.162 -177.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 59.4 Cg_endo -73.65 -35.5 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.056 1.17 . . . . 0.0 110.927 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.75 -53.71 9.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.966 -174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -67.13 -35.81 80.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.113 0.483 . . . . 0.0 110.617 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.39 -28.85 70.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.297 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.95 -43.74 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.543 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.868 ' O ' HG23 ' A' ' 58' ' ' THR . 92.3 m-85 -61.84 -32.68 73.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.361 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.83 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.441 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.87 -42.89 99.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.989 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 57' ' ' LEU . 10.7 mp -72.92 -35.64 67.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.921 0.361 . . . . 0.0 111.566 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.868 HG23 ' O ' ' A' ' 54' ' ' PHE . 29.9 p -54.41 -59.72 4.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.909 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.99 -29.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.76 -27.55 69.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.197 0.522 . . . . 0.0 112.184 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.59 98.57 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.608 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.25 -22.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.8 -47.88 70.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.426 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -51.27 -36.94 44.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.167 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.3 -54.54 6.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.625 0.726 . . . . 0.0 110.967 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.14 -45.0 96.46 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.559 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.39 -30.67 71.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.779 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 43.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.468 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.1 t0 48.06 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.13 147.59 39.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.603 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -69.85 147.46 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.599 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 14' ' ' GLY . 10.2 tp . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -90.9 -40.05 5.66 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-O 122.021 0.789 . . . . 0.0 113.324 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.4 m -60.12 -48.05 83.33 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.908 -1.146 . . . . 0.0 113.438 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -81.11 -49.68 10.56 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 118.889 -1.125 . . . . 0.0 111.292 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 17' ' ' LEU 0.255 4.2 mm? -49.11 -40.17 31.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.956 0.502 . . . . 0.0 111.769 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 14' ' ' GLY . 74.8 t -70.31 -32.5 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.843 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.14 61.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.621 0.248 . . . . 0.0 111.661 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.04 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.923 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.0 p -70.09 -26.31 63.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.973 0.416 . . . . 0.0 110.928 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 p -60.9 -22.59 64.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.624 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' LEU . 98.0 m-85 -87.94 -9.67 52.87 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.248 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 m -57.79 -48.26 97.48 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.372 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.4 Cg_endo -60.37 -40.73 55.64 Favored 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.444 2.096 . . . . 0.0 112.75 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.92 -27.13 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' PHE . 57.2 tp -76.54 -40.44 49.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 29' ' ' ILE . 9.1 p -59.41 -50.72 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.569 ' N ' HG13 ' A' ' 28' ' ' VAL . 64.5 mt -60.53 -35.84 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 30' ' ' LEU . 5.1 tt -53.43 -44.94 69.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.262 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.87 -38.95 92.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.121 0.962 . . . . 0.0 111.3 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.8 70.76 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.411 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.74 -43.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.68 -42.04 94.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.942 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.72 -52.36 46.37 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 36' ' ' LEU . 11.1 mp -62.84 -33.93 76.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 p -59.93 -18.9 48.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.72 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.943 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -50.81 -25.75 4.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.24 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.0 p -96.33 8.98 42.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 150.99 22.09 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.15 148.16 41.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.669 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 tp -43.8 -45.67 7.42 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.176 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.16 -29.69 20.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.2 -0.26 56.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.792 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.45 0.14 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 CA-C-N 119.366 0.984 . . . . 0.0 110.382 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.41 -32.38 24.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.228 0.537 . . . . 0.0 111.503 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -51.57 -52.08 63.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.172 -178.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 Cg_endo -75.64 -36.39 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.061 1.174 . . . . 0.0 110.932 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.6 7.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.579 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.05 -36.45 82.06 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.461 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -62.96 -28.34 70.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.316 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.34 -44.65 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.349 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.43 -34.86 78.89 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 52' ' ' ALA . 15.9 tt -65.76 -37.34 79.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.24 98.28 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.99 -31.88 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.559 0.218 . . . . 0.0 110.543 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 m -57.18 -57.87 10.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.792 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.008 0.432 . . . . 0.0 111.405 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 49.7 t80 -61.96 -27.34 68.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.13 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.42 99.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.615 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.28 -22.0 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -65.94 -46.94 76.36 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -49.85 -35.1 21.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.26 -37.72 66.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.538 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -72.15 -43.73 64.19 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 69' ' ' ASP . 87.9 mt-30 -50.54 -44.14 56.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.255 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . 67.28 -39.38 0.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 67' ' ' GLN . 98.4 m-20 57.05 33.86 24.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.876 0.37 . . . . 0.0 110.413 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' SER . . . -64.03 -38.44 91.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 71' ' ' SER . 23.8 p 44.23 96.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.6 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.59 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -84.53 -40.55 8.29 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.938 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -59.36 -48.06 83.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.436 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 17' ' ' LEU . 65.9 p -59.47 -61.55 2.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 117.597 -1.641 . . . . 0.0 111.989 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 16' ' ' THR . 47.0 tp -56.26 -43.29 78.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.531 0.605 . . . . 0.0 111.955 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 14' ' ' GLY . 69.3 t -65.03 -33.8 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 0.0 111.131 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -71.19 -19.14 62.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.535 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.09 -46.06 90.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.715 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.4 t -75.35 -26.08 58.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 110.881 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 57.7 p -61.1 -21.87 64.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.772 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 27' ' ' LEU . 55.8 m-85 -89.54 -9.08 51.22 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.195 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.594 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -58.19 -48.23 97.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.262 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 24' ' ' THR . 37.2 Cg_endo -62.5 -34.95 74.14 Favored 'Trans proline' 0 N--CA 1.51 2.459 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -85.29 -26.13 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.308 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.5 tp -77.71 -40.35 41.54 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.137 -0.352 . . . . 0.0 111.35 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.9 p -60.03 -52.2 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.495 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.9 pt -62.78 -37.74 79.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.88 -44.35 74.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.826 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.23 -37.68 88.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.061 0.934 . . . . 0.0 111.274 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.29 -43.75 75.41 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.709 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.22 -43.79 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.65 -34.09 60.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.429 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.32 -51.83 56.37 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.863 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 36' ' ' LEU . 11.2 mp -62.24 -32.93 73.67 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' OG1' ' A' ' 40' ' ' THR . 8.4 p -58.62 -18.52 31.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.79 -36.83 77.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 109.951 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -55.46 -25.48 36.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.429 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 37' ' ' SER . 72.1 p -95.48 8.76 42.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.52 151.11 22.28 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.78 147.89 43.02 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 43' ' ' LEU . 2.1 tt -44.87 -46.21 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.644 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.02 -30.03 20.27 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.784 -1.197 . . . . 0.0 114.156 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -87.47 -0.9 57.48 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.391 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.16 -0.68 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 110.44 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.6 tp -84.24 -33.37 24.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.547 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.92 -52.52 60.67 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 58.6 Cg_endo -73.71 -37.53 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.053 1.169 . . . . 0.0 111.123 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -44.12 -52.23 7.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.561 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.07 -35.82 81.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.085 0.469 . . . . 0.0 110.539 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 49' ' ' PRO . . . -59.91 -27.97 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.872 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 49' ' ' PRO . 35.1 mm -64.42 -44.21 97.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.259 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 58' ' ' THR . 88.6 m-85 -62.1 -33.44 74.44 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.14 -42.36 95.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.78 -42.37 98.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.445 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -70.87 -31.98 68.83 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.69 -0.3 . . . . 0.0 110.549 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 21.0 m -56.62 -58.73 6.81 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.269 -0.973 . . . . 0.0 108.783 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.99 -28.09 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 CA-C-O 121.436 0.636 . . . . 0.0 111.172 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -65.3 -29.19 69.93 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.493 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.44 84.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.351 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.74 -21.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -66.38 -50.38 63.68 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.048 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 72.7 ttt180 -49.29 -34.38 15.29 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -77.51 -55.32 5.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.696 0.76 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -60.09 -45.35 93.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.405 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -30.47 71.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.104 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -74.65 43.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 55.36 81.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 144.77 31.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.452 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 p -76.21 161.65 28.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.8 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.618 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.3 -29.73 67.66 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.033 0.444 . . . . 0.0 110.508 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.85 -47.92 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.466 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.61 65.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.53 -30.48 71.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.037 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 24' ' ' THR . 9.2 t -50.71 -19.83 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.034 0.533 . . . . 0.0 111.004 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.1 p -58.93 -21.23 57.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -87.48 -8.34 56.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.648 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.6 m -60.62 -48.62 92.82 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.736 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 24' ' ' THR . 32.2 Cg_endo -60.71 -40.28 56.28 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 121.512 1.475 . . . . 0.0 111.55 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -75.12 -25.78 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.688 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.1 tp -73.18 -37.52 66.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.887 -0.508 . . . . 0.0 110.584 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.9 -50.08 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.403 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.15 -32.01 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.149 0.499 . . . . 0.0 110.432 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -55.57 -45.06 77.39 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.207 -177.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.55 -38.21 90.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.32 1.057 . . . . 0.0 111.133 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.1 -43.43 88.56 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.771 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.2 t -61.38 -44.32 98.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.89 -34.52 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.07 -51.09 60.42 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.17 -32.53 71.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -59.21 -18.56 37.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.859 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.54 72.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 109.759 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.3 mm? -49.18 -24.58 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.592 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -95.58 10.99 34.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.125 0.488 . . . . 0.0 110.294 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.23 151.33 21.95 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.41 145.78 43.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.735 -0.274 . . . . 0.0 111.103 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.6 tp -44.36 -42.33 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.945 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 64.5 t0 -88.39 -30.27 19.62 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -88.96 0.4 56.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.677 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.2 p -101.91 -1.09 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.792 1.178 . . . . 0.0 109.931 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.81 -35.17 20.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.23 0.538 . . . . 0.0 111.892 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -52.58 1.19 Allowed Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.21 -34.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.994 2.462 . . . . 0.0 115.176 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.72 -48.82 52.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.312 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 tp -71.28 -27.38 63.38 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.18 63.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 4.0 pt -63.02 -40.95 90.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.978 0.418 . . . . 0.0 110.803 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 76.0 t80 -59.77 -36.27 76.33 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.727 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.17 -42.56 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.715 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.47 -41.5 97.14 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.2 mt -72.66 -32.57 65.93 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.798 -0.236 . . . . 0.0 110.707 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 m -55.28 -57.68 10.82 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.599 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.38 -30.11 48.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 45.0 t80 -62.86 -28.01 69.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.13 91.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.481 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.77 -22.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -66.6 -47.47 72.59 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -54.23 -40.35 67.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 0.0 111.557 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -70.34 -40.31 74.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.821 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -69.4 -44.85 70.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.159 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ALA . 11.7 tp-100 -49.82 -46.15 50.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 17' ' ' LEU . 10.9 mp -71.45 -29.9 65.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.028 0.442 . . . . 0.0 110.91 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -60.33 -48.75 86.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.0 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.82 -24.62 65.31 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.336 0.588 . . . . 0.0 110.602 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.1 tp -62.31 -30.35 71.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.911 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.586 ' O ' ' OG1' ' A' ' 24' ' ' THR . 32.5 t -50.89 -19.52 1.03 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -57.53 -20.54 32.39 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.384 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' A' ' 27' ' ' LEU . 55.7 m-85 -86.14 -10.83 54.08 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.734 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.605 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 p -55.88 -49.08 95.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.394 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -58.37 -43.27 47.74 Favored 'Trans proline' 0 N--CA 1.511 2.501 0 C-N-CA 122.408 2.072 . . . . 0.0 113.012 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.34 -25.34 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.089 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 23' ' ' PHE . 1.2 mm? -73.42 -38.18 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.517 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.82 -51.64 70.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.982 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.97 -42.58 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 33' ' ' VAL . 53.4 tp -53.13 -45.09 68.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.36 -37.25 86.47 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.19 0.995 . . . . 0.0 111.452 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.73 -42.99 69.21 Favored Glycine 0 CA--C 1.543 1.811 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.134 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.9 p -57.75 -33.72 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.13 -39.32 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.04 -51.51 53.37 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 119.192 -1.48 . . . . 0.0 109.542 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.46 -32.13 69.96 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.995 0.426 . . . . 0.0 110.038 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t -57.32 -17.85 14.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.51 -38.84 75.31 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -48.25 -25.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.917 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 m -96.2 9.82 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 110.436 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.87 150.74 21.76 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.09 146.68 43.42 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.262 -0.175 . . . . 0.0 110.77 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.8 tp -43.86 -43.5 6.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.771 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 37.7 p30 -89.02 -29.85 19.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.1 t80 -88.35 0.29 56.34 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.671 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.0 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.7 p -100.02 0.44 10.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-N 119.56 1.073 . . . . 0.0 109.839 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.6 mm? -85.67 -34.93 21.19 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.151 -0.968 . . . . 0.0 112.379 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 -52.19 1.22 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -91.62 -34.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.492 2.128 . . . . 0.0 114.967 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.51 -50.4 38.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.239 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 tp -70.59 -27.26 63.97 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.935 0.397 . . . . 0.0 111.043 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.46 65.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.896 0.379 . . . . 0.0 111.672 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.91 -33.17 71.51 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.47 -42.33 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.61 98.26 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.486 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -32.09 68.52 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.863 -0.198 . . . . 0.0 110.664 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -56.33 -58.35 8.38 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.172 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.02 -27.71 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.078 0.466 . . . . 0.0 110.778 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -66.16 -29.39 69.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.53 83.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.381 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 pt -70.64 -21.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.84 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -66.28 -49.19 67.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -49.31 -31.54 9.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.709 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 tttt -76.33 -54.29 6.97 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.93 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.25 -44.09 95.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.119 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.33 -38.45 63.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.25 -28.8 64.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.294 0.568 . . . . 0.0 110.732 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -60.1 -46.14 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.847 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.74 65.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.478 0.656 . . . . 0.0 110.898 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.54 -29.62 68.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.039 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.0 t -52.21 -21.33 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.685 0.279 . . . . 0.0 111.132 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.2 m -59.27 -20.5 54.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LEU . 72.6 m-85 -89.87 -10.04 46.77 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.567 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.649 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 m -56.66 -48.06 97.88 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 24' ' ' THR . 34.2 Cg_endo -61.96 -37.05 68.24 Favored 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 122.372 2.048 . . . . 0.0 111.938 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.01 -26.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.939 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 23' ' ' PHE . 52.2 tp -77.24 -40.63 44.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.659 0.266 . . . . 0.0 111.517 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.7 p -60.42 -52.33 62.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.792 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.613 ' N ' HG13 ' A' ' 28' ' ' VAL . 10.4 tp -64.09 -39.07 84.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 109.659 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 44.2 tp -52.8 -44.27 66.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.555 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.93 -34.26 77.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.963 0.887 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.48 -42.09 74.61 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.289 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.7 p -56.49 -32.02 35.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.06 -33.23 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -51.24 60.03 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.55 -29.06 58.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 p -55.56 -17.16 4.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.79 77.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.348 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 39' ' ' LEU . 10.7 mp -49.68 -23.8 1.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.786 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 p -94.57 11.17 31.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.299 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.95 154.66 24.76 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 46' ' ' VAL . 1.1 t80 -73.5 147.79 43.73 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.632 -0.334 . . . . 0.0 110.268 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.5 mm? -44.57 -44.25 8.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.44 -0.315 . . . . 0.0 110.416 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 47.0 p-10 -88.94 -30.36 18.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 8.3 t80 -88.69 1.24 55.46 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.312 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 8.3 p -100.26 1.02 10.48 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-N 119.493 1.042 . . . . 0.0 110.701 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.87 -31.88 23.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.635 0.731 . . . . 0.0 112.797 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.29 -51.58 13.26 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.432 -178.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 72.7 Cg_endo -83.84 -26.5 1.97 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 123.565 2.844 . . . . 0.0 113.465 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -68.95 -50.52 48.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.562 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -70.29 -27.66 64.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.052 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.2 -29.31 67.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 111.574 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.2 mm -65.93 -43.65 92.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.174 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -62.24 -32.65 73.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.39 -41.86 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.81 -41.97 97.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.862 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.9 mm? -73.06 -31.37 64.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -56.68 -59.36 5.12 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.583 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.21 -27.47 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.76 -27.1 69.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.742 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.76 97.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.222 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.6 mt -68.35 -21.99 26.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -66.99 -48.01 69.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -49.41 -34.46 16.43 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.898 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 tptm -77.18 -55.7 5.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.885 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -59.94 -44.0 94.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.839 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -55.47 -38.52 69.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.733 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.09 -29.05 64.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.184 0.516 . . . . 0.0 110.941 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -60.25 -47.48 92.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.735 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.82 66.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.573 0.701 . . . . 0.0 110.768 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.69 -28.62 68.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.4 p -51.69 -20.95 2.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.175 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 m -58.35 -19.97 39.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 27' ' ' LEU . 69.9 m-85 -89.59 -10.48 45.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.65 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 6.6 m -55.5 -48.87 95.41 Favored Pre-proline 0 CA--C 1.528 0.125 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -60.98 -36.48 82.61 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.786 2.324 . . . . 0.0 111.558 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -79.13 -25.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.899 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' PHE . 55.5 tp -74.19 -39.56 63.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.019 0.438 . . . . 0.0 112.122 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 29' ' ' ILE . 3.9 m -60.61 -52.05 65.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' H ' HG23 ' A' ' 28' ' ' VAL . 22.4 pt -63.79 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 34' ' ' VAL . 55.9 tp -54.93 -43.93 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.357 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.3 -34.68 78.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.94 0.876 . . . . 0.0 111.067 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.68 94.49 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.91 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 33' ' ' VAL . 2.4 p -65.4 -47.42 86.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' LEU . 27.1 m -70.3 -31.83 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.821 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.53 -52.3 52.66 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.196 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 39' ' ' LEU . 97.9 mt -55.51 -29.13 58.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -54.59 -15.7 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.017 0.823 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.84 -40.37 84.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 111.716 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -44.02 -23.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.983 ' N ' HD13 ' A' ' 39' ' ' LEU . 23.2 m -93.73 11.72 28.11 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.679 0.752 . . . . 0.0 109.48 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.71 152.93 22.8 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.37 146.59 42.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.544 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 43' ' ' LEU . 11.0 mp -43.82 -44.92 7.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.373 -0.204 . . . . 0.0 111.498 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 66.4 t0 -88.74 -31.3 18.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.92 2.69 50.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.188 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.027 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.9 p -101.95 0.78 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.151 0.887 . . . . 0.0 110.384 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.05 -34.68 17.89 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.049 -1.032 . . . . 0.0 112.912 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -79.42 -53.02 1.09 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.007 -177.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 73.8 Cg_endo -90.29 -35.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 122.424 2.083 . . . . 0.0 113.919 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -72.02 -51.93 19.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.249 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.5 -28.02 67.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.892 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 48' ' ' LEU . . . -58.54 -28.05 65.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.402 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.96 -43.76 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.532 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -61.56 -32.21 72.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.627 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -63.62 -41.39 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.53 96.72 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.64 -31.4 65.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -56.68 -60.38 3.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.555 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.85 -27.96 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-O 120.863 0.363 . . . . 0.0 110.527 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.04 -27.14 68.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.164 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.38 97.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.357 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.96 -21.96 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.69 -46.38 75.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 84.8 mtp180 -49.52 -30.16 7.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.193 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.11 -56.74 4.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -58.97 -44.63 91.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.247 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.37 -30.18 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.38 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.09 -30.39 68.69 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.217 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.17 -47.38 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.341 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.08 66.79 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.53 -30.26 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.015 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 24' ' ' THR . 8.2 m -50.31 -20.18 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.859 0.464 . . . . 0.0 110.7 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 6.4 m -57.87 -19.7 31.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -88.09 -10.74 49.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.82 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -58.78 -43.67 98.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.29 -177.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 37.8 Cg_exo -63.15 -43.22 19.65 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.011 2.474 . . . . 0.0 111.212 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.28 -25.65 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.35 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.6 tt -72.58 -38.02 68.0 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.933 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.49 -51.25 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.107 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.57 -35.06 73.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.0 tt -56.44 -44.1 80.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.555 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.9 -36.9 85.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.55 1.166 . . . . 0.0 110.797 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.78 76.84 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.908 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.4 p -58.22 -34.86 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.86 -35.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.302 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.49 -51.79 56.7 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.28 -33.34 74.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.5 m -58.91 -18.8 36.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.741 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.57 79.67 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 109.968 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -25.53 25.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.1 6.98 47.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.147 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.649 ' HA3' HG12 ' A' ' 46' ' ' VAL . . . -90.07 155.21 24.29 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 46' ' ' VAL . 1.1 t80 -74.02 145.81 44.24 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.736 -0.273 . . . . 0.0 111.247 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 tp -43.03 -41.64 3.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.644 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -87.57 -27.43 22.57 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -86.04 1.32 50.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.067 -1.424 . . . . 0.0 113.184 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 42' ' ' TYR . 20.1 m -96.76 1.06 10.52 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.026 0 CA-C-N 119.738 1.154 . . . . 0.0 110.614 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 mt -83.38 -32.56 26.12 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 111.437 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -51.59 -52.12 63.25 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.158 -177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 Cg_endo -76.74 -36.89 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.27 1.313 . . . . 0.0 110.992 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.41 -53.93 8.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.835 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.54 -37.07 82.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.871 -0.518 . . . . 0.0 110.943 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -63.79 -30.96 71.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.441 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.89 -44.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.924 0.392 . . . . 0.0 110.97 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 58' ' ' THR . 59.0 t80 -64.47 -36.78 85.29 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.152 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.97 -42.87 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.99 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.54 -42.58 99.69 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.618 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.868 0.334 . . . . 0.0 110.635 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 54' ' ' PHE . 53.5 m -55.8 -58.83 6.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.449 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.71 -29.17 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.61 -29.17 70.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.16 80.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.193 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.8 mm -68.6 -22.59 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -66.88 -49.52 65.36 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.685 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -54.34 -41.23 68.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.442 0.639 . . . . 0.0 111.333 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.15 -40.36 71.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.624 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -71.07 -45.63 63.41 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.382 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 57.3 tt0 -50.26 -49.94 51.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.405 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.25 52.2 tp -47.29 -35.0 7.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.86 -32.77 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.874 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -74.04 -20.27 60.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.788 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.86 -46.85 88.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.158 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -75.59 -25.86 57.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 110.097 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -61.37 -21.87 64.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.407 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 27' ' ' LEU . 70.8 m-85 -87.38 -8.12 56.96 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.304 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m -61.85 -49.38 86.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.479 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 24' ' ' THR . 27.6 Cg_endo -59.93 -41.6 52.11 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.429 1.419 . . . . 0.0 111.26 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.87 -25.99 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.598 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.1 tt -71.76 -37.34 70.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.292 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.53 -50.18 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.13 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.42 -36.91 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.113 0.483 . . . . 0.0 109.702 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.12 -46.35 65.31 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.67 -37.8 88.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.146 0.974 . . . . 0.0 111.484 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.14 -43.83 93.3 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.921 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.36 -44.39 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.23 -38.19 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.6 -51.7 54.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.65 -34.0 74.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.193 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -58.19 -18.2 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.18 81.66 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.91 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 tp -50.71 -25.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.34 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -95.86 9.87 39.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.54 22.62 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 147.3 44.39 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.686 -0.302 . . . . 0.0 110.614 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 43' ' ' LEU . 58.7 mt -44.86 -44.91 9.93 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.338 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.74 -30.3 19.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -88.0 -0.68 57.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.298 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.3 2.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 119.301 0.955 . . . . 0.0 110.204 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -82.87 -32.69 27.28 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 110.607 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.2 mp -51.72 -52.89 56.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.922 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.5 Cg_endo -73.88 -36.02 3.9 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.052 1.168 . . . . 0.0 111.583 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.13 -53.53 10.23 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.158 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -66.16 -35.38 80.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.19 0.45 . . . . 0.0 110.297 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.9 -29.4 70.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.454 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.97 -43.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.48 -34.43 77.74 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.36 -42.31 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.5 97.99 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.442 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -73.43 -32.03 64.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.5 m -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.743 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.5 -29.48 46.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.19 -27.42 68.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.23 0.538 . . . . 0.0 112.235 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.63 -44.12 97.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.497 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.6 -22.35 25.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.454 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -67.04 -47.56 71.0 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.369 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -50.76 -37.66 43.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.326 0.584 . . . . 0.0 110.958 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -71.46 -43.98 65.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.768 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -70.36 -46.62 63.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.215 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.7 -29.98 70.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.741 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.785 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -54.39 -43.67 71.61 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.616 0.644 . . . . 0.0 111.823 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -69.79 -32.5 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.14 -42.71 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.776 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -74.27 -26.24 60.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.342 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.5 p -61.38 -22.73 65.23 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 27' ' ' LEU . 84.2 m-85 -87.42 -9.38 54.84 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.671 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.573 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 3.1 m -58.67 -49.0 95.82 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.919 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.0 Cg_endo -61.17 -36.42 80.86 Favored 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.257 1.971 . . . . 0.0 112.402 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.03 -26.38 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.79 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.0 tt -80.07 -40.22 28.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.83 0.287 . . . . 0.0 111.526 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.2 p -58.93 -52.01 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.7 tt -61.84 -32.46 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.21 0.529 . . . . 0.0 110.044 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -58.13 -43.29 87.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.061 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.7 -38.15 90.01 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.382 1.087 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.01 -44.52 98.1 Favored Glycine 0 CA--C 1.549 2.209 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.664 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 33' ' ' VAL . 5.7 m -66.61 -47.04 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.093 0.446 . . . . 0.0 110.946 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 30' ' ' LEU . 31.6 m -70.79 -32.05 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.661 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.83 -52.04 55.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.41 -34.44 77.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.974 0.416 . . . . 0.0 110.157 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 40' ' ' THR . 16.5 p -59.86 -19.37 50.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.614 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.6 -36.51 71.84 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.039 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.7 tp -45.48 -23.01 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -93.62 11.98 26.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.547 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.93 152.0 22.62 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.71 147.18 45.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -44.31 -45.03 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.285 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 65.8 t0 -89.61 -30.61 18.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 122.553 1.168 . . . . 0.0 114.146 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -86.62 -0.88 57.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.477 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.38 1.61 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 119.106 0.866 . . . . 0.0 110.129 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.8 mp -83.12 -32.79 26.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.86 -52.26 62.95 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 61.3 Cg_endo -74.67 -35.55 3.43 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.18 1.253 . . . . 0.0 111.105 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.45 10.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.884 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -66.72 -36.71 83.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.635 0.255 . . . . 0.0 110.601 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -58.26 -27.25 63.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.049 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.32 -42.96 97.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -60.39 -32.72 71.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.882 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.7 mp -64.96 -42.08 93.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.4 -42.73 97.63 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.4 mt -70.86 -32.49 69.51 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.717 -0.284 . . . . 0.0 110.772 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 m -56.41 -57.97 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.752 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 62' ' ' ILE . 77.9 mt -61.55 -29.02 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 120.928 0.394 . . . . 0.0 111.156 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 24' ' ' THR . 40.7 t80 -63.98 -28.42 69.8 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.68 77.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.954 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 59' ' ' ILE . 14.2 tt -68.14 -23.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.346 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.11 -49.41 67.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.343 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -49.39 -32.04 10.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.922 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.42 -54.79 6.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.822 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -61.99 -45.11 95.06 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.553 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 26.2 mt-30 -65.91 -30.24 70.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.136 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.779 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -47.81 -38.26 15.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.27 -32.87 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.93 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.99 61.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.84 -45.23 95.33 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.595 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.2 p -72.29 -26.01 61.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.99 0.424 . . . . 0.0 110.609 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.2 -22.62 64.92 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.945 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -89.76 -9.06 50.73 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.255 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 16.8 m -58.59 -48.3 97.15 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 24' ' ' THR . 33.4 Cg_endo -61.35 -37.96 68.46 Favored 'Trans proline' 0 N--CA 1.513 2.634 0 C-N-CA 122.314 2.009 . . . . 0.0 112.54 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.45 -26.33 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.865 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.9 tt -79.17 -40.54 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.91 0.323 . . . . 0.0 111.657 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.6 p -58.92 -52.12 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.56 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.1 tt -61.21 -32.66 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.512 . . . . 0.0 110.094 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.573 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.71 -44.34 85.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.572 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.34 -38.87 92.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.269 1.033 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.64 -43.65 86.21 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.782 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.21 -44.42 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.6 -35.55 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.592 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.7 -51.8 56.84 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.67 -32.83 73.03 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -18.51 28.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.04 79.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.13 0.491 . . . . 0.0 109.998 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.2 mm? -52.42 -25.14 9.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.132 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -95.84 8.89 42.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.074 0.464 . . . . 0.0 110.155 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.79 152.02 22.76 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -73.48 146.48 44.9 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -44.62 -45.24 9.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.503 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.84 -30.61 18.82 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -86.79 -0.7 56.87 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.46 2.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 119.079 0.854 . . . . 0.0 109.77 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -83.02 -32.55 26.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 111.278 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -51.23 -52.6 57.43 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.162 -177.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 59.4 Cg_endo -73.65 -35.5 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.056 1.17 . . . . 0.0 110.927 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.75 -53.71 9.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.966 -174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -67.13 -35.81 80.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.113 0.483 . . . . 0.0 110.617 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.39 -28.85 70.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.297 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.95 -43.74 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.543 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.868 ' O ' HG23 ' A' ' 58' ' ' THR . 92.3 m-85 -61.84 -32.68 73.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.361 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.83 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.441 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.87 -42.89 99.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.989 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 57' ' ' LEU . 10.7 mp -72.92 -35.64 67.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.921 0.361 . . . . 0.0 111.566 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.868 HG23 ' O ' ' A' ' 54' ' ' PHE . 29.9 p -54.41 -59.72 4.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.909 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.99 -29.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.76 -27.55 69.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.197 0.522 . . . . 0.0 112.184 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.59 98.57 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.608 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.25 -22.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.8 -47.88 70.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.426 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -51.27 -36.94 44.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.167 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.3 -54.54 6.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.625 0.726 . . . . 0.0 110.967 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.14 -45.0 96.46 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.559 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.39 -30.67 71.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.779 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.468 179.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.559 0.219 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 17' ' ' LEU 0.255 4.2 mm? -49.11 -40.17 31.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.956 0.502 . . . . 0.0 111.769 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.31 -32.5 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.843 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.14 61.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.621 0.248 . . . . 0.0 111.661 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.04 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.923 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.0 p -70.09 -26.31 63.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.973 0.416 . . . . 0.0 110.928 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 p -60.9 -22.59 64.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.624 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' LEU . 98.0 m-85 -87.94 -9.67 52.87 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.248 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 m -57.79 -48.26 97.48 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.372 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.4 Cg_endo -60.37 -40.73 55.64 Favored 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.444 2.096 . . . . 0.0 112.75 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.92 -27.13 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' PHE . 57.2 tp -76.54 -40.44 49.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 29' ' ' ILE . 9.1 p -59.41 -50.72 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.569 ' N ' HG13 ' A' ' 28' ' ' VAL . 64.5 mt -60.53 -35.84 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 30' ' ' LEU . 5.1 tt -53.43 -44.94 69.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.262 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.87 -38.95 92.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.121 0.962 . . . . 0.0 111.3 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.8 70.76 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.411 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.74 -43.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.68 -42.04 94.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.942 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.72 -52.36 46.37 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 36' ' ' LEU . 11.1 mp -62.84 -33.93 76.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 p -59.93 -18.9 48.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.72 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.943 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -50.81 -25.75 4.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.24 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.0 p -96.33 8.98 42.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 150.99 22.09 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.15 148.16 41.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.669 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 tp -43.8 -45.67 7.42 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.176 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.16 -29.69 20.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.2 -0.26 56.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.792 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.45 0.14 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 CA-C-N 119.366 0.984 . . . . 0.0 110.382 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.41 -32.38 24.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.228 0.537 . . . . 0.0 111.503 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -51.57 -52.08 63.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.172 -178.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 Cg_endo -75.64 -36.39 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.061 1.174 . . . . 0.0 110.932 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.6 7.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.579 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.05 -36.45 82.06 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.461 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -62.96 -28.34 70.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.316 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.34 -44.65 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.349 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.43 -34.86 78.89 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 52' ' ' ALA . 15.9 tt -65.76 -37.34 79.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.24 98.28 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.99 -31.88 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.559 0.218 . . . . 0.0 110.543 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 m -57.18 -57.87 10.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.792 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.008 0.432 . . . . 0.0 111.405 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 49.7 t80 -61.96 -27.34 68.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.13 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.42 99.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.615 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.28 -22.0 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -65.94 -46.94 76.36 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -49.85 -35.1 21.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.26 -37.72 66.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.538 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -72.15 -43.73 64.19 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 87.9 mt-30 -50.54 -44.14 56.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.255 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.141 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 17' ' ' LEU . 65.9 p . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 16' ' ' THR . 47.0 tp -56.26 -43.29 78.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.531 0.605 . . . . 0.0 111.955 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.03 -33.8 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 0.0 111.131 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -71.19 -19.14 62.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.535 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.09 -46.06 90.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.715 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.4 t -75.35 -26.08 58.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 110.881 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 57.7 p -61.1 -21.87 64.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.772 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 27' ' ' LEU . 55.8 m-85 -89.54 -9.08 51.22 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.195 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.594 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -58.19 -48.23 97.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.262 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 24' ' ' THR . 37.2 Cg_endo -62.5 -34.95 74.14 Favored 'Trans proline' 0 N--CA 1.51 2.459 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -85.29 -26.13 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.308 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.5 tp -77.71 -40.35 41.54 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.137 -0.352 . . . . 0.0 111.35 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.9 p -60.03 -52.2 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.495 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.9 pt -62.78 -37.74 79.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.88 -44.35 74.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.826 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.23 -37.68 88.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.061 0.934 . . . . 0.0 111.274 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.29 -43.75 75.41 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.709 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.22 -43.79 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.65 -34.09 60.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.429 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.32 -51.83 56.37 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.863 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 36' ' ' LEU . 11.2 mp -62.24 -32.93 73.67 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' OG1' ' A' ' 40' ' ' THR . 8.4 p -58.62 -18.52 31.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.79 -36.83 77.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 109.951 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -55.46 -25.48 36.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.429 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 37' ' ' SER . 72.1 p -95.48 8.76 42.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.52 151.11 22.28 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.78 147.89 43.02 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . 2.1 tt -44.87 -46.21 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.644 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.02 -30.03 20.27 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.784 -1.197 . . . . 0.0 114.156 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -87.47 -0.9 57.48 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.391 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.16 -0.68 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 110.44 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.6 tp -84.24 -33.37 24.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.547 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.92 -52.52 60.67 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 58.6 Cg_endo -73.71 -37.53 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.053 1.169 . . . . 0.0 111.123 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -44.12 -52.23 7.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.561 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.07 -35.82 81.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.085 0.469 . . . . 0.0 110.539 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 49' ' ' PRO . . . -59.91 -27.97 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.872 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 49' ' ' PRO . 35.1 mm -64.42 -44.21 97.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.259 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 58' ' ' THR . 88.6 m-85 -62.1 -33.44 74.44 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.14 -42.36 95.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.78 -42.37 98.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.445 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -70.87 -31.98 68.83 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.69 -0.3 . . . . 0.0 110.549 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 21.0 m -56.62 -58.73 6.81 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.269 -0.973 . . . . 0.0 108.783 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.99 -28.09 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 CA-C-O 121.436 0.636 . . . . 0.0 111.172 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -65.3 -29.19 69.93 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.493 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.44 84.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.351 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.74 -21.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -66.38 -50.38 63.68 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.048 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 72.7 ttt180 -49.29 -34.38 15.29 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -77.51 -55.32 5.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.696 0.76 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -60.09 -45.35 93.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.405 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -64.92 -30.47 71.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.104 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mm . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.882 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -54.55 -32.75 53.55 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.78 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.6 m -59.59 -47.06 87.05 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.0 m -57.16 -48.83 77.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.976 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.3 -29.73 67.66 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.033 0.444 . . . . 0.0 110.508 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 14' ' ' GLY . 42.8 t -60.85 -47.92 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.466 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 -24.61 65.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.53 -30.48 71.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.037 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 24' ' ' THR . 9.2 t -50.71 -19.83 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.034 0.533 . . . . 0.0 111.004 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.1 p -58.93 -21.23 57.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -87.48 -8.34 56.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.648 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.6 m -60.62 -48.62 92.82 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.736 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 24' ' ' THR . 32.2 Cg_endo -60.71 -40.28 56.28 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 121.512 1.475 . . . . 0.0 111.55 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -75.12 -25.78 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.688 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.1 tp -73.18 -37.52 66.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.887 -0.508 . . . . 0.0 110.584 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.9 -50.08 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.403 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.15 -32.01 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.149 0.499 . . . . 0.0 110.432 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -55.57 -45.06 77.39 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.207 -177.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.55 -38.21 90.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.32 1.057 . . . . 0.0 111.133 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.1 -43.43 88.56 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.771 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.2 t -61.38 -44.32 98.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.89 -34.52 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.07 -51.09 60.42 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.17 -32.53 71.15 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -59.21 -18.56 37.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.859 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.54 72.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 109.759 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.3 mm? -49.18 -24.58 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.592 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -95.58 10.99 34.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.125 0.488 . . . . 0.0 110.294 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.23 151.33 21.95 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.41 145.78 43.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.735 -0.274 . . . . 0.0 111.103 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.6 tp -44.36 -42.33 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.945 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 64.5 t0 -88.39 -30.27 19.62 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -88.96 0.4 56.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.677 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.2 p -101.91 -1.09 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.792 1.178 . . . . 0.0 109.931 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.81 -35.17 20.84 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.23 0.538 . . . . 0.0 111.892 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -52.58 1.19 Allowed Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.21 -34.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.994 2.462 . . . . 0.0 115.176 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.72 -48.82 52.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.312 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.8 tp -71.28 -27.38 63.38 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.18 63.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 4.0 pt -63.02 -40.95 90.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.978 0.418 . . . . 0.0 110.803 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 76.0 t80 -59.77 -36.27 76.33 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.727 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.17 -42.56 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.715 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.47 -41.5 97.14 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.2 mt -72.66 -32.57 65.93 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.798 -0.236 . . . . 0.0 110.707 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 m -55.28 -57.68 10.82 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.911 -1.116 . . . . 0.0 108.599 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.38 -30.11 48.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 45.0 t80 -62.86 -28.01 69.73 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -46.13 91.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.481 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.77 -22.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -66.6 -47.47 72.59 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -54.23 -40.35 67.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 0.0 111.557 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -70.34 -40.31 74.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.821 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -69.4 -44.85 70.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.159 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 68' ' ' ALA . 11.7 tp-100 -49.82 -46.15 50.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' ALA . . . 31.37 65.62 0.17 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 98.4 m-20 54.43 -80.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.558 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 69' ' ' ASP . . . 79.4 -148.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.555 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.5 m -60.09 -41.83 93.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.033 -0.985 . . . . 0.0 110.593 -179.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.562 HG23 ' N ' ' A' ' 14' ' ' GLY . 20.8 tt . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.887 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.99 -34.22 51.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.296 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 p -59.7 -48.9 79.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.267 1.033 . . . . 0.0 108.371 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 25.9 p -54.93 -47.3 74.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.528 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 17' ' ' LEU . 10.9 mp -71.45 -29.9 65.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.028 0.442 . . . . 0.0 110.91 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 14' ' ' GLY . 26.3 t -60.33 -48.75 86.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.0 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.82 -24.62 65.31 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.336 0.588 . . . . 0.0 110.602 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.1 tp -62.31 -30.35 71.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.911 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.586 ' O ' ' OG1' ' A' ' 24' ' ' THR . 32.5 t -50.89 -19.52 1.03 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -57.53 -20.54 32.39 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.384 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB3' HD23 ' A' ' 27' ' ' LEU . 55.7 m-85 -86.14 -10.83 54.08 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.734 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.605 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 p -55.88 -49.08 95.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.394 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -58.37 -43.27 47.74 Favored 'Trans proline' 0 N--CA 1.511 2.501 0 C-N-CA 122.408 2.072 . . . . 0.0 113.012 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.34 -25.34 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.089 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.49 HD23 ' HB3' ' A' ' 23' ' ' PHE . 1.2 mm? -73.42 -38.18 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.517 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.82 -51.64 70.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.982 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.97 -42.58 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 33' ' ' VAL . 53.4 tp -53.13 -45.09 68.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.984 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.36 -37.25 86.47 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.19 0.995 . . . . 0.0 111.452 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.73 -42.99 69.21 Favored Glycine 0 CA--C 1.543 1.811 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.134 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.9 p -57.75 -33.72 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.13 -39.32 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.04 -51.51 53.37 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 119.192 -1.48 . . . . 0.0 109.542 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.46 -32.13 69.96 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.995 0.426 . . . . 0.0 110.038 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 t -57.32 -17.85 14.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.51 -38.84 75.31 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -48.25 -25.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.917 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 m -96.2 9.82 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 110.436 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.87 150.74 21.76 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.09 146.68 43.42 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.262 -0.175 . . . . 0.0 110.77 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.8 tp -43.86 -43.5 6.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.771 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 37.7 p30 -89.02 -29.85 19.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.1 t80 -88.35 0.29 56.34 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 113.265 -1.789 . . . . 0.0 112.671 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.0 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 6.7 p -100.02 0.44 10.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-N 119.56 1.073 . . . . 0.0 109.839 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.6 mm? -85.67 -34.93 21.19 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.151 -0.968 . . . . 0.0 112.379 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 -52.19 1.22 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -91.62 -34.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.492 2.128 . . . . 0.0 114.967 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -70.51 -50.4 38.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.239 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 tp -70.59 -27.26 63.97 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.935 0.397 . . . . 0.0 111.043 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.46 65.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.896 0.379 . . . . 0.0 111.672 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.91 -33.17 71.51 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.47 -42.33 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.61 98.26 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.486 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -32.09 68.52 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.863 -0.198 . . . . 0.0 110.664 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -56.33 -58.35 8.38 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.172 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.02 -27.71 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.078 0.466 . . . . 0.0 110.778 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -66.16 -29.39 69.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.53 83.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.381 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 pt -70.64 -21.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.84 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -66.28 -49.19 67.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -49.31 -31.54 9.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.709 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 88.7 tttt -76.33 -54.29 6.97 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.93 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.25 -44.09 95.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.119 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -53.33 -38.45 63.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . -51.37 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.544 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -71.16 -42.48 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.062 0.458 . . . . 0.0 110.78 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 53.19 92.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.352 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.1 m -70.22 148.97 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.595 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.579 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.908 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.89 -37.57 58.09 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.0 p -59.18 -48.98 79.62 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.313 1.054 . . . . 0.0 108.95 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.2 p -55.73 -48.02 75.91 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.497 -1.228 . . . . 0.0 109.754 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.25 -28.8 64.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.294 0.568 . . . . 0.0 110.732 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 14' ' ' GLY . 20.0 t -60.1 -46.14 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.847 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -19.74 65.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.478 0.656 . . . . 0.0 110.898 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.54 -29.62 68.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.039 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.0 t -52.21 -21.33 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.685 0.279 . . . . 0.0 111.132 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.2 m -59.27 -20.5 54.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LEU . 72.6 m-85 -89.87 -10.04 46.77 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.567 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.649 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 m -56.66 -48.06 97.88 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 24' ' ' THR . 34.2 Cg_endo -61.96 -37.05 68.24 Favored 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 122.372 2.048 . . . . 0.0 111.938 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.01 -26.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.939 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 23' ' ' PHE . 52.2 tp -77.24 -40.63 44.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.659 0.266 . . . . 0.0 111.517 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.7 p -60.42 -52.33 62.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.792 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.613 ' N ' HG13 ' A' ' 28' ' ' VAL . 10.4 tp -64.09 -39.07 84.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 109.659 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 33' ' ' VAL . 44.2 tp -52.8 -44.27 66.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.555 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.93 -34.26 77.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.963 0.887 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.48 -42.09 74.61 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.289 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.7 p -56.49 -32.02 35.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.06 -33.23 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -51.24 60.03 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.55 -29.06 58.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 p -55.56 -17.16 4.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.79 77.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.348 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 39' ' ' LEU . 10.7 mp -49.68 -23.8 1.94 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.786 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 p -94.57 11.17 31.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.299 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.95 154.66 24.76 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 46' ' ' VAL . 1.1 t80 -73.5 147.79 43.73 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.632 -0.334 . . . . 0.0 110.268 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.5 mm? -44.57 -44.25 8.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.44 -0.315 . . . . 0.0 110.416 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 47.0 p-10 -88.94 -30.36 18.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 8.3 t80 -88.69 1.24 55.46 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.312 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 8.3 p -100.26 1.02 10.48 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.389 0 CA-C-N 119.493 1.042 . . . . 0.0 110.701 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.87 -31.88 23.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.635 0.731 . . . . 0.0 112.797 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.29 -51.58 13.26 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.432 -178.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 72.7 Cg_endo -83.84 -26.5 1.97 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 123.565 2.844 . . . . 0.0 113.465 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -68.95 -50.52 48.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.562 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -70.29 -27.66 64.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.052 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.2 -29.31 67.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 111.574 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.2 mm -65.93 -43.65 92.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.174 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -62.24 -32.65 73.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.939 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.39 -41.86 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.81 -41.97 97.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.862 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.9 mm? -73.06 -31.37 64.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -56.68 -59.36 5.12 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.583 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.21 -27.47 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.76 -27.1 69.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.742 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.76 97.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.222 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.6 mt -68.35 -21.99 26.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -66.99 -48.01 69.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -49.41 -34.46 16.43 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.898 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 tptm -77.18 -55.7 5.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.885 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -59.94 -44.0 94.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.839 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -55.47 -38.52 69.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.733 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' LYS . . . -52.11 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.818 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -177.04 67.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.603 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -47.88 148.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 0.0 110.55 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -70.34 144.36 51.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.577 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.903 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.01 -37.63 54.2 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.0 p -59.32 -47.1 86.69 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.058 0.933 . . . . 0.0 109.347 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -56.81 -48.38 78.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.948 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.09 -29.05 64.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.184 0.516 . . . . 0.0 110.941 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 14' ' ' GLY . 23.1 t -60.25 -47.48 92.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.735 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -21.82 66.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.573 0.701 . . . . 0.0 110.768 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.69 -28.62 68.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.4 p -51.69 -20.95 2.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.175 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.7 m -58.35 -19.97 39.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 27' ' ' LEU . 69.9 m-85 -89.59 -10.48 45.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.65 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 6.6 m -55.5 -48.87 95.41 Favored Pre-proline 0 CA--C 1.528 0.125 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 24' ' ' THR . 28.9 Cg_endo -60.98 -36.48 82.61 Favored 'Trans proline' 0 N--CA 1.503 2.061 0 C-N-CA 122.786 2.324 . . . . 0.0 111.558 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.6 t -79.13 -25.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.899 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 23' ' ' PHE . 55.5 tp -74.19 -39.56 63.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.019 0.438 . . . . 0.0 112.122 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 29' ' ' ILE . 3.9 m -60.61 -52.05 65.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' H ' HG23 ' A' ' 28' ' ' VAL . 22.4 pt -63.79 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 34' ' ' VAL . 55.9 tp -54.93 -43.93 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.357 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.3 -34.68 78.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.94 0.876 . . . . 0.0 111.067 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.68 94.49 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.91 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.437 ' H ' HG12 ' A' ' 33' ' ' VAL . 2.4 p -65.4 -47.42 86.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' LEU . 27.1 m -70.3 -31.83 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.821 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.53 -52.3 52.66 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.196 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 39' ' ' LEU . 97.9 mt -55.51 -29.13 58.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -54.59 -15.7 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.017 0.823 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -58.84 -40.37 84.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 111.716 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -44.02 -23.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.983 ' N ' HD13 ' A' ' 39' ' ' LEU . 23.2 m -93.73 11.72 28.11 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.679 0.752 . . . . 0.0 109.48 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -89.71 152.93 22.8 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.37 146.59 42.88 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.544 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 43' ' ' LEU . 11.0 mp -43.82 -44.92 7.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.373 -0.204 . . . . 0.0 111.498 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 66.4 t0 -88.74 -31.3 18.5 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.92 2.69 50.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 113.768 -1.56 . . . . 0.0 113.188 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.027 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 9.9 p -101.95 0.78 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.151 0.887 . . . . 0.0 110.384 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.05 -34.68 17.89 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.049 -1.032 . . . . 0.0 112.912 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -79.42 -53.02 1.09 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.007 -177.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 73.8 Cg_endo -90.29 -35.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 122.424 2.083 . . . . 0.0 113.919 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -72.02 -51.93 19.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.249 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.5 -28.02 67.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.892 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 48' ' ' LEU . . . -58.54 -28.05 65.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.402 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.96 -43.76 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.532 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -61.56 -32.21 72.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.627 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mm -63.62 -41.39 92.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.53 96.72 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.64 -31.4 65.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -56.68 -60.38 3.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.555 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.3 mm -60.85 -27.96 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-O 120.863 0.363 . . . . 0.0 110.527 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -62.04 -27.14 68.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.164 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.38 97.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.357 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.96 -21.96 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.69 -46.38 75.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 84.8 mtp180 -49.52 -30.16 7.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.193 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.11 -56.74 4.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 79.1 mtp85 -58.97 -44.63 91.57 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.247 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.37 -30.18 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.38 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -80.4 39.64 0.47 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.813 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 66' ' ' ARG . 5.4 p30 -171.52 -176.64 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.242 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' SER . . . 63.62 -81.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.695 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 p 43.05 18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ALA . 13.9 t . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.555 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.851 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -53.86 -35.18 52.65 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.9 m -60.28 -47.78 84.53 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -56.6 -48.59 77.09 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.245 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.8 mt -69.09 -30.39 68.69 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.217 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 14' ' ' GLY . 27.2 t -60.17 -47.38 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.341 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.08 66.79 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.53 -30.26 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.015 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 24' ' ' THR . 8.2 m -50.31 -20.18 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.859 0.464 . . . . 0.0 110.7 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 6.4 m -57.87 -19.7 31.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -88.09 -10.74 49.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.82 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -58.78 -43.67 98.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.29 -177.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 37.8 Cg_exo -63.15 -43.22 19.65 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.011 2.474 . . . . 0.0 111.212 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.28 -25.65 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.35 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.6 tt -72.58 -38.02 68.0 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.933 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.49 -51.25 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.107 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.57 -35.06 73.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.0 tt -56.44 -44.1 80.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.555 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.9 -36.9 85.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.55 1.166 . . . . 0.0 110.797 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.78 76.84 Favored Glycine 0 CA--C 1.548 2.123 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.908 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 30' ' ' LEU . 1.4 p -58.22 -34.86 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.86 -35.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.302 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.49 -51.79 56.7 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.28 -33.34 74.45 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.5 m -58.91 -18.8 36.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.741 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.57 79.67 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 109.968 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -25.53 25.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.178 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.1 6.98 47.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.949 0.404 . . . . 0.0 110.147 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.649 ' HA3' HG12 ' A' ' 46' ' ' VAL . . . -90.07 155.21 24.29 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 46' ' ' VAL . 1.1 t80 -74.02 145.81 44.24 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.736 -0.273 . . . . 0.0 111.247 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 tp -43.03 -41.64 3.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.644 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -87.57 -27.43 22.57 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -86.04 1.32 50.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.067 -1.424 . . . . 0.0 113.184 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 42' ' ' TYR . 20.1 m -96.76 1.06 10.52 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.026 0 CA-C-N 119.738 1.154 . . . . 0.0 110.614 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 mt -83.38 -32.56 26.12 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 111.437 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -51.59 -52.12 63.25 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.158 -177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 Cg_endo -76.74 -36.89 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.27 1.313 . . . . 0.0 110.992 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.41 -53.93 8.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.835 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.54 -37.07 82.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.871 -0.518 . . . . 0.0 110.943 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -63.79 -30.96 71.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.441 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.89 -44.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.924 0.392 . . . . 0.0 110.97 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.405 ' CE2' ' OG1' ' A' ' 58' ' ' THR . 59.0 t80 -64.47 -36.78 85.29 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.152 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.97 -42.87 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.99 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.54 -42.58 99.69 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.618 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -74.37 -33.03 62.97 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.868 0.334 . . . . 0.0 110.635 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.405 ' OG1' ' CE2' ' A' ' 54' ' ' PHE . 53.5 m -55.8 -58.83 6.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.401 -0.919 . . . . 0.0 109.449 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.71 -29.17 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.61 -29.17 70.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.16 80.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.193 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.8 mm -68.6 -22.59 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -66.88 -49.52 65.36 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.685 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -54.34 -41.23 68.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.442 0.639 . . . . 0.0 111.333 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.15 -40.36 71.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.624 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -71.07 -45.63 63.41 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.382 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 57.3 tt0 -50.26 -49.94 51.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . 64.91 -40.92 0.29 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.405 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' GLN . 2.0 m-20 176.6 -68.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.15 121.89 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.9 t -62.28 -43.41 98.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.686 -179.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.88 -42.96 5.54 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-O 122.14 0.856 . . . . 0.0 113.519 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' VAL . 70.6 p -59.46 -48.75 80.44 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.79 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -50.39 8.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 119.514 -0.875 . . . . 0.0 112.632 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.25 52.2 tp -47.29 -35.0 7.29 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 15' ' ' THR . 7.9 p -62.86 -32.77 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.874 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -74.04 -20.27 60.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.788 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.86 -46.85 88.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.158 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -75.59 -25.86 57.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 110.097 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -61.37 -21.87 64.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.407 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 27' ' ' LEU . 70.8 m-85 -87.38 -8.12 56.96 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.304 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m -61.85 -49.38 86.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.479 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 24' ' ' THR . 27.6 Cg_endo -59.93 -41.6 52.11 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.429 1.419 . . . . 0.0 111.26 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.87 -25.99 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.598 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.1 tt -71.76 -37.34 70.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.292 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.53 -50.18 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.13 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.42 -36.91 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.113 0.483 . . . . 0.0 109.702 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.12 -46.35 65.31 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.67 -37.8 88.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.146 0.974 . . . . 0.0 111.484 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.14 -43.83 93.3 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.921 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.36 -44.39 99.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.23 -38.19 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.599 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.6 -51.7 54.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.65 -34.0 74.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.193 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -58.19 -18.2 24.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.18 81.66 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.91 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 tp -50.71 -25.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.34 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -95.86 9.87 39.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.54 22.62 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 147.3 44.39 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.686 -0.302 . . . . 0.0 110.614 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 43' ' ' LEU . 58.7 mt -44.86 -44.91 9.93 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.338 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.74 -30.3 19.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -88.0 -0.68 57.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.605 -1.634 . . . . 0.0 113.298 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.3 2.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 CA-C-N 119.301 0.955 . . . . 0.0 110.204 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -82.87 -32.69 27.28 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.931 0.396 . . . . 0.0 110.607 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.2 mp -51.72 -52.89 56.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.922 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 59.5 Cg_endo -73.88 -36.02 3.9 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.052 1.168 . . . . 0.0 111.583 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.13 -53.53 10.23 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.158 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -66.16 -35.38 80.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.19 0.45 . . . . 0.0 110.297 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.9 -29.4 70.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.454 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.97 -43.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.48 -34.43 77.74 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.36 -42.31 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.5 97.99 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.442 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -73.43 -32.03 64.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.5 m -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.743 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.5 -29.48 46.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.19 -27.42 68.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.23 0.538 . . . . 0.0 112.235 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.63 -44.12 97.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.497 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.6 -22.35 25.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.454 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -67.04 -47.56 71.0 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.369 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -50.76 -37.66 43.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.326 0.584 . . . . 0.0 110.958 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -71.46 -43.98 65.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.768 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -70.36 -46.62 63.73 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.215 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.7 -29.98 70.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.741 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.65 46.37 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.785 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 67.9 t0 -79.61 -109.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.518 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 69' ' ' ASP . . . 67.29 -57.91 0.42 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.88 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 69' ' ' ASP . 46.3 t -149.33 148.55 29.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.455 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.642 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 14' ' ' GLY . 20.3 tt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 13' ' ' ILE . . . -84.48 -41.03 8.04 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.97 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 19' ' ' ALA . 96.2 m -60.5 -48.0 83.69 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.433 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.8 p -59.7 -61.75 2.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 117.713 -1.595 . . . . 0.0 111.977 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -54.39 -43.67 71.61 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.616 0.644 . . . . 0.0 111.823 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 14' ' ' GLY . 95.7 t -69.79 -32.5 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 15' ' ' THR . . . -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.14 -42.71 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.776 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -74.27 -26.24 60.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.342 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.5 p -61.38 -22.73 65.23 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 27' ' ' LEU . 84.2 m-85 -87.42 -9.38 54.84 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.671 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.573 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 3.1 m -58.67 -49.0 95.82 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.919 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.0 Cg_endo -61.17 -36.42 80.86 Favored 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.257 1.971 . . . . 0.0 112.402 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.03 -26.38 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.79 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' PHE . 7.0 tt -80.07 -40.22 28.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.83 0.287 . . . . 0.0 111.526 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.2 p -58.93 -52.01 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.7 tt -61.84 -32.46 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.21 0.529 . . . . 0.0 110.044 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -58.13 -43.29 87.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.061 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.6 tp -63.7 -38.15 90.01 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.382 1.087 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.01 -44.52 98.1 Favored Glycine 0 CA--C 1.549 2.209 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.664 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 33' ' ' VAL . 5.7 m -66.61 -47.04 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.093 0.446 . . . . 0.0 110.946 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 30' ' ' LEU . 31.6 m -70.79 -32.05 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.661 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.83 -52.04 55.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -63.41 -34.44 77.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.974 0.416 . . . . 0.0 110.157 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 40' ' ' THR . 16.5 p -59.86 -19.37 50.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.614 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -57.6 -36.51 71.84 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.039 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.7 tp -45.48 -23.01 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 37' ' ' SER . 0.7 OUTLIER -93.62 11.98 26.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.547 -178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 38' ' ' ALA . . . -88.93 152.0 22.62 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.71 147.18 45.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -44.31 -45.03 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.285 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 65.8 t0 -89.61 -30.61 18.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 122.553 1.168 . . . . 0.0 114.146 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -86.62 -0.88 57.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.477 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.38 1.61 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 119.106 0.866 . . . . 0.0 110.129 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.8 mp -83.12 -32.79 26.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.86 -52.26 62.95 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 61.3 Cg_endo -74.67 -35.55 3.43 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.18 1.253 . . . . 0.0 111.105 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.45 10.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.884 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -66.72 -36.71 83.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.635 0.255 . . . . 0.0 110.601 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -58.26 -27.25 63.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.049 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.32 -42.96 97.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -60.39 -32.72 71.59 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.882 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.7 mp -64.96 -42.08 93.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.4 -42.73 97.63 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.4 mt -70.86 -32.49 69.51 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.717 -0.284 . . . . 0.0 110.772 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 m -56.41 -57.97 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.752 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 62' ' ' ILE . 77.9 mt -61.55 -29.02 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 120.928 0.394 . . . . 0.0 111.156 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' HG23 ' A' ' 24' ' ' THR . 40.7 t80 -63.98 -28.42 69.8 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.68 77.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.954 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 59' ' ' ILE . 14.2 tt -68.14 -23.42 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.346 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.11 -49.41 67.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.343 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -49.39 -32.04 10.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.922 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.42 -54.79 6.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.822 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -61.99 -45.11 95.06 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.553 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 26.2 mt-30 -65.91 -30.24 70.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.136 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 67' ' ' GLN . . . 35.1 86.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.779 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -62.65 -41.32 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.67 33.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.536 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -65.78 145.17 56.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.688 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.494 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -90.28 -42.22 5.29 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.4 m -60.78 -50.03 75.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.888 -1.156 . . . . 0.0 112.721 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -78.37 -50.29 12.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.789 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -47.81 -38.26 15.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 14' ' ' GLY . 53.9 t -66.27 -32.87 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.93 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.99 61.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.84 -45.23 95.33 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.595 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.2 p -72.29 -26.01 61.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.99 0.424 . . . . 0.0 110.609 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.2 -22.62 64.92 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.945 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 27' ' ' LEU . 56.0 m-85 -89.76 -9.06 50.73 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.255 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 16.8 m -58.59 -48.3 97.15 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 24' ' ' THR . 33.4 Cg_endo -61.35 -37.96 68.46 Favored 'Trans proline' 0 N--CA 1.513 2.634 0 C-N-CA 122.314 2.009 . . . . 0.0 112.54 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -85.45 -26.33 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.865 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 23' ' ' PHE . 6.9 tt -79.17 -40.54 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.91 0.323 . . . . 0.0 111.657 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.6 p -58.92 -52.12 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.56 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.1 tt -61.21 -32.66 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.512 . . . . 0.0 110.094 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.71 -44.34 85.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.572 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.34 -38.87 92.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.269 1.033 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.64 -43.65 86.21 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.482 -1.69 . . . . 0.0 111.782 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.21 -44.42 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.6 -35.55 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.592 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.7 -51.8 56.84 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.67 -32.83 73.03 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -18.51 28.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.04 79.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.13 0.491 . . . . 0.0 109.998 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.2 mm? -52.42 -25.14 9.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.132 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -95.84 8.89 42.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.074 0.464 . . . . 0.0 110.155 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.79 152.02 22.76 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -73.48 146.48 44.9 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -44.62 -45.24 9.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.503 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.84 -30.61 18.82 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -86.79 -0.7 56.87 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.46 2.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 119.079 0.854 . . . . 0.0 109.77 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -83.02 -32.55 26.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 111.278 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -51.23 -52.6 57.43 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.162 -177.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 59.4 Cg_endo -73.65 -35.5 4.56 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.056 1.17 . . . . 0.0 110.927 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.75 -53.71 9.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.966 -174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.8 mp -67.13 -35.81 80.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.113 0.483 . . . . 0.0 110.617 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 49' ' ' PRO . . . -62.39 -28.85 70.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.297 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.95 -43.74 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.543 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.868 ' O ' HG23 ' A' ' 58' ' ' THR . 92.3 m-85 -61.84 -32.68 73.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.361 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.83 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.441 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.87 -42.89 99.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.989 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 57' ' ' LEU . 10.7 mp -72.92 -35.64 67.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.921 0.361 . . . . 0.0 111.566 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.868 HG23 ' O ' ' A' ' 54' ' ' PHE . 29.9 p -54.41 -59.72 4.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.909 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.99 -29.29 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.76 -27.55 69.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.197 0.522 . . . . 0.0 112.184 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.59 98.57 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.608 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.25 -22.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.8 -47.88 70.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.426 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -51.27 -36.94 44.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.167 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.3 -54.54 6.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.625 0.726 . . . . 0.0 110.967 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.14 -45.0 96.46 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.559 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.39 -30.67 71.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.779 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 43.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.468 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.1 t0 48.06 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.13 147.59 39.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.603 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -69.85 147.46 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.54 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.599 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 14' ' ' GLY . 10.2 tp . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -90.9 -40.05 5.66 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-O 122.021 0.789 . . . . 0.0 113.324 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.4 m -60.12 -48.05 83.33 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 113.908 -1.146 . . . . 0.0 113.438 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 p -81.11 -49.68 10.56 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 118.889 -1.125 . . . . 0.0 111.292 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 17' ' ' LEU 0.255 4.2 mm? -49.11 -40.17 31.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.956 0.502 . . . . 0.0 111.769 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 14' ' ' GLY . 74.8 t -70.31 -32.5 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.843 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.14 61.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.621 0.248 . . . . 0.0 111.661 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.04 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.923 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.0 p -70.09 -26.31 63.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.973 0.416 . . . . 0.0 110.928 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 p -60.9 -22.59 64.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.624 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' LEU . 98.0 m-85 -87.94 -9.67 52.87 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.248 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 m -57.79 -48.26 97.48 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.372 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 24' ' ' THR . 35.4 Cg_endo -60.37 -40.73 55.64 Favored 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.444 2.096 . . . . 0.0 112.75 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.92 -27.13 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' PHE . 57.2 tp -76.54 -40.44 49.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 29' ' ' ILE . 9.1 p -59.41 -50.72 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.569 ' N ' HG13 ' A' ' 28' ' ' VAL . 64.5 mt -60.53 -35.84 66.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 30' ' ' LEU . 5.1 tt -53.43 -44.94 69.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.262 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.87 -38.95 92.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.121 0.962 . . . . 0.0 111.3 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.8 70.76 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.411 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.74 -43.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.68 -42.04 94.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.942 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.72 -52.36 46.37 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 36' ' ' LEU . 11.1 mp -62.84 -33.93 76.26 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 p -59.93 -18.9 48.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.72 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.943 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 tp -50.81 -25.75 4.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.24 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.0 p -96.33 8.98 42.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.269 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 150.99 22.09 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.15 148.16 41.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.304 -0.158 . . . . 0.0 110.669 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 tp -43.8 -45.67 7.42 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.176 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -88.16 -29.69 20.35 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -88.2 -0.26 56.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.792 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.45 0.14 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 CA-C-N 119.366 0.984 . . . . 0.0 110.382 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.41 -32.38 24.15 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.228 0.537 . . . . 0.0 111.503 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -51.57 -52.08 63.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.172 -178.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 Cg_endo -75.64 -36.39 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.061 1.174 . . . . 0.0 110.932 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.6 7.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.579 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.05 -36.45 82.06 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.461 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -62.96 -28.34 70.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.316 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.34 -44.65 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.349 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.43 -34.86 78.89 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 52' ' ' ALA . 15.9 tt -65.76 -37.34 79.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.24 98.28 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.99 -31.88 69.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.559 0.218 . . . . 0.0 110.543 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 m -57.18 -57.87 10.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.792 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.008 0.432 . . . . 0.0 111.405 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 24' ' ' THR . 49.7 t80 -61.96 -27.34 68.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.13 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.42 99.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.615 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -68.28 -22.0 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -65.94 -46.94 76.36 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -49.85 -35.1 21.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.26 -37.72 66.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.538 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -72.15 -43.73 64.19 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 69' ' ' ASP . 87.9 mt-30 -50.54 -44.14 56.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.255 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . 67.28 -39.38 0.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 67' ' ' GLN . 98.4 m-20 57.05 33.86 24.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.876 0.37 . . . . 0.0 110.413 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' SER . . . -64.03 -38.44 91.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.489 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 71' ' ' SER . 23.8 p 44.23 96.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.6 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.59 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -84.53 -40.55 8.29 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.938 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -59.36 -48.06 83.05 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.436 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 17' ' ' LEU . 65.9 p -59.47 -61.55 2.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 117.597 -1.641 . . . . 0.0 111.989 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' OG1' ' A' ' 16' ' ' THR . 47.0 tp -56.26 -43.29 78.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.531 0.605 . . . . 0.0 111.955 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 14' ' ' GLY . 69.3 t -65.03 -33.8 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 0.0 111.131 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -71.19 -19.14 62.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.535 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.09 -46.06 90.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.715 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.4 t -75.35 -26.08 58.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 110.881 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 57.7 p -61.1 -21.87 64.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.772 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 27' ' ' LEU . 55.8 m-85 -89.54 -9.08 51.22 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.195 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.594 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -58.19 -48.23 97.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.262 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 24' ' ' THR . 37.2 Cg_endo -62.5 -34.95 74.14 Favored 'Trans proline' 0 N--CA 1.51 2.459 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -85.29 -26.13 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.308 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' PHE . 54.5 tp -77.71 -40.35 41.54 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.137 -0.352 . . . . 0.0 111.35 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 29' ' ' ILE . 7.9 p -60.03 -52.2 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.495 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' N ' HG13 ' A' ' 28' ' ' VAL . 20.9 pt -62.78 -37.74 79.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.88 -44.35 74.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.826 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 99.0 mt -64.23 -37.68 88.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.061 0.934 . . . . 0.0 111.274 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.29 -43.75 75.41 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.709 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.22 -43.79 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.65 -34.09 60.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.429 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.32 -51.83 56.37 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 119.385 -1.388 . . . . 0.0 109.863 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 36' ' ' LEU . 11.2 mp -62.24 -32.93 73.67 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' OG1' ' A' ' 40' ' ' THR . 8.4 p -58.62 -18.52 31.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.546 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.79 -36.83 77.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 109.951 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -55.46 -25.48 36.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.429 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 37' ' ' SER . 72.1 p -95.48 8.76 42.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 0.0 110.116 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.52 151.11 22.28 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.78 147.89 43.02 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . 2.1 tt -44.87 -46.21 10.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.644 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.02 -30.03 20.27 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.784 -1.197 . . . . 0.0 114.156 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -87.47 -0.9 57.48 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 113.493 -1.685 . . . . 0.0 112.391 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.16 -0.68 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 118.934 0.788 . . . . 0.0 110.44 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.6 tp -84.24 -33.37 24.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.88 0.371 . . . . 0.0 111.547 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mp -51.92 -52.52 60.67 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 58.6 Cg_endo -73.71 -37.53 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.053 1.169 . . . . 0.0 111.123 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -44.12 -52.23 7.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.561 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.07 -35.82 81.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.085 0.469 . . . . 0.0 110.539 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 49' ' ' PRO . . . -59.91 -27.97 67.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.872 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 49' ' ' PRO . 35.1 mm -64.42 -44.21 97.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.259 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 58' ' ' THR . 88.6 m-85 -62.1 -33.44 74.44 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.14 -42.36 95.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.78 -42.37 98.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.445 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.4 mt -70.87 -31.98 68.83 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.69 -0.3 . . . . 0.0 110.549 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 54' ' ' PHE . 21.0 m -56.62 -58.73 6.81 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.269 -0.973 . . . . 0.0 108.783 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.99 -28.09 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 CA-C-O 121.436 0.636 . . . . 0.0 111.172 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -65.3 -29.19 69.93 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.493 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.44 84.18 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.351 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.74 -21.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -66.38 -50.38 63.68 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.048 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 72.7 ttt180 -49.29 -34.38 15.29 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -77.51 -55.32 5.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.696 0.76 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -60.09 -45.35 93.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.405 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -64.92 -30.47 71.47 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.104 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -74.65 43.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 55.36 81.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.83 144.77 31.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.452 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 p -76.21 161.65 28.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.8 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.618 -179.971 . . . . . . . . 0 0 . 1 stop_ save_